"Parent Molecule ChEMBL ID";"Parent Molecule Name";"Parent Molecule Type";"Max Phase";"First Approval";"USAN Stem";"Smiles";"Mechanism of Action";"Mechanism Comment";"Selectivity Comment";"Target ChEMBL ID";"Target Name";"Action Type";"Target Type";"Target Organism";"Binding Site Name";"Binding Site Comment";"References";"Synonyms";"ATC Codes";"Level 4 ATC Codes";"Level 3 ATC Codes";"Level 2 ATC Codes";"Level 1 ATC Codes";"Parent Molecule ChEMBL ID"
"CHEMBL82301";"VICRIVIROC";"Small molecule";"3";"";"'-vir-; -viroc'";"COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C";"C-C chemokine receptor type 5 antagonist";"Discontinueddue to disappointing results in Ph2 and Ph3 studies.";"";"CHEMBL274";"C-C chemokine receptor type 5";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 16304152 URL: http://europepmc.org/abstract/MED/16304152";"Vicriviroc Maleate (MI, USAN)|Vicriviroc (INN, MI)|";"";"";"";"";"";"CHEMBL82301"
"CHEMBL52440";"DEXTROMETHORPHAN";"Small molecule";"4";"1982";"'-orphan'";"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3";"Sigma opioid receptor agonist";"";"";"CHEMBL287";"Sigma opioid receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 2897648 URL: http://europepmc.org/abstract/MED/2897648|Type: Wikipedia RefID: Dextromethorphan URL: http://en.wikipedia.org/wiki/Dextromethorphan|Type: Wikipedia RefID: Nmda_receptor_antagonist URL: http://en.wikipedia.org/wiki/Nmda_receptor_antagonist";"Dextromethorphan Polistirex (FDA, USAN)|Dextromethorphan Hydrobromide (BAN, FDA, JAN, USP)|Deudextromethorphan (USAN)|Dextromethorphan (BAN, INN, USP)|Deudextromethorphan hydrobromide (USAN)|";"N07XX59 | R05DA09";"N07XX - Other nervous system drugs | R05DA - Opium alkaloids and derivatives";"N07X - OTHER NERVOUS SYSTEM DRUGS | R05D - COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS";"N07 - OTHER NERVOUS SYSTEM DRUGS | R05 - COUGH AND COLD PREPARATIONS";"N - NERVOUS SYSTEM | R - RESPIRATORY SYSTEM";"CHEMBL52440"
"CHEMBL1535";"HYDROXYCHLOROQUINE";"Small molecule";"4";"1955";"";"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12";"Toll-like receptor 7 antagonist";"";"";"CHEMBL5936";"Toll-like receptor 7";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2007/009768s041lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/009768s041lbl.pdf|Type: PubMed RefID: 17970883 URL: http://europepmc.org/abstract/MED/17970883|Type: PubMed RefID: 18220957 URL: http://europepmc.org/abstract/MED/18220957";"Hydroxychloroquine sulfate (FDA, USP)|Hydroxychloroquine Sulfate (MI)|Hydroxychloroquine (BAN, INN, MI)|";"P01BA02";"P01BA - Aminoquinolines";"P01B - ANTIMALARIALS";"P01 - ANTIPROTOZOALS";"P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS";"CHEMBL1535"
"CHEMBL370143";"PAROMOMYCIN";"Small molecule";"4";"1969";"'-mycin'";"NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O";"Bacterial 70S ribosome inhibitor";"";"";"CHEMBL2363135";"Bacterial 70S ribosome";"INHIBITOR";"PROTEIN NUCLEIC-ACID COMPLEX";"Bacteria";"16S ribosomal RNA";"16s RRNA";"Type: DailyMed RefID: archiveid=103824 URL: http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=103824|Type: PubMed RefID: 11587639 URL: http://europepmc.org/abstract/MED/11587639";"Paromomycin Sulfate (FDA, JAN, USP)|Paromomycin (BAN, INN, MI)|";"A07AA06";"A07AA - Antibiotics";"A07A - INTESTINAL ANTIINFECTIVES";"A07 - ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL370143"
"CHEMBL32";"MOXIFLOXACIN";"Small molecule";"4";"1999";"'-oxacin'";"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12";"Bacterial DNA gyrase inhibitor";"";"";"CHEMBL2311224";"Bacterial DNA gyrase";"INHIBITOR";"PROTEIN COMPLEX";"Bacteria";"";"";"Type: DailyMed RefID: setid=56b4f979-bf20-4908-9d7c-5536221d77f8 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56b4f979-bf20-4908-9d7c-5536221d77f8";"Moxifloxacin HCl (FDA, JAN, MI, USAN, USP)|Moxifloxacin (BAN, INN, MI)|";"J01MA14 | S01AE07";"J01MA - Fluoroquinolones | S01AE - Fluoroquinolones";"J01M - QUINOLONE ANTIBACTERIALS | S01A - ANTIINFECTIVES";"J01 - ANTIBACTERIALS FOR SYSTEMIC USE | S01 - OPHTHALMOLOGICALS";"J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS";"CHEMBL32"
"CHEMBL98";"VORINOSTAT";"Small molecule";"4";"2006";"'-stat'";"O=C(CCCCCCC(=O)Nc1ccccc1)NO";"Histone deacetylase 2 inhibitor";"";"";"CHEMBL1937";"Histone deacetylase 2";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13";"Vorinostat (FDA, INN, JAN, MI, USAN)|";"L01XX38";"L01XX - Other antineoplastic agents";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL98"
"CHEMBL1200807";"NORELGESTROMIN";"Small molecule";"4";"2001";"'-estr-; -gest-'";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC";"Progesterone receptor agonist";"";"";"CHEMBL208";"Progesterone receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=f8e8a69e-a018-469a-af56-e20f61fe4e06#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f8e8a69e-a018-469a-af56-e20f61fe4e06#nlm34090-1";"Deacetylnorgestimate (USP)|Norelgestromin (BAN, FDA, INN, MI, USAN)|";"";"";"";"";"";"CHEMBL1200807"
"CHEMBL1535";"HYDROXYCHLOROQUINE";"Small molecule";"4";"1955";"";"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12";"Ferriprotoporphyrin IX inhibitor";"inhibits polymerisation";"";"CHEMBL613897";"Ferriprotoporphyrin IX";"INHIBITOR";"SMALL MOLECULE";"Plasmodium falciparum";"";"";"Type: PubMed RefID: 14967191 URL: http://europepmc.org/abstract/MED/14967191|Type: Wikipedia RefID: Hemozoin URL: http://en.wikipedia.org/wiki/Hemozoin";"Hydroxychloroquine sulfate (FDA, USP)|Hydroxychloroquine Sulfate (MI)|Hydroxychloroquine (BAN, INN, MI)|";"P01BA02";"P01BA - Aminoquinolines";"P01B - ANTIMALARIALS";"P01 - ANTIPROTOZOALS";"P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS";"CHEMBL1535"
"CHEMBL112";"ACETAMINOPHEN";"Small molecule";"4";"1968";"";"CC(=O)Nc1ccc(O)cc1";"Cyclooxygenase inhibitor";"";"";"CHEMBL2094253";"Cyclooxygenase";"INHIBITOR";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: PubMed RefID: 12660052 URL: http://europepmc.org/abstract/MED/12660052|Type: PubMed RefID: 15662292 URL: http://europepmc.org/abstract/MED/15662292|Type: PubMed RefID: 15987694 URL: http://europepmc.org/abstract/MED/15987694|Type: PubMed RefID: 17884974 URL: http://europepmc.org/abstract/MED/17884974|Type: PubMed RefID: 20862299 URL: http://europepmc.org/abstract/MED/20862299|Type: Wikipedia RefID: Acetaminophen#Mechanism_of_action URL: http://en.wikipedia.org/wiki/Acetaminophen#Mechanism_of_action";"Acetaminophen (FDA, JAN, MI, USP)|Paracetamol (BAN, DCF, INN)|";"N02BE71 | N02BE51 | N02BE01";"N02BE - Anilides | N02BE - Anilides | N02BE - Anilides";"N02B - OTHER ANALGESICS AND ANTIPYRETICS | N02B - OTHER ANALGESICS AND ANTIPYRETICS | N02B - OTHER ANALGESICS AND ANTIPYRETICS";"N02 - ANALGESICS | N02 - ANALGESICS | N02 - ANALGESICS";"N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM";"CHEMBL112"
"CHEMBL25";"ASPIRIN";"Small molecule";"4";"1950";"";"CC(=O)Oc1ccccc1C(=O)O";"Cyclooxygenase inhibitor";"";"";"CHEMBL2094253";"Cyclooxygenase";"INHIBITOR";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: PubMed RefID: 17131625 URL: http://europepmc.org/abstract/MED/17131625|Type: PubMed RefID: 17258197 URL: http://europepmc.org/abstract/MED/17258197|Type: Wikipedia RefID: Aspirin#Mechanism_of_action URL: http://en.wikipedia.org/wiki/Aspirin#Mechanism_of_action";"Aspirin (BAN, FDA, JAN, MI, USP)|Aspirin dl-lysine (JAN)|Lysine acetylsalicylate (MI)|";"N02BA01 | N02BA51 | N02BA71 | A01AD05 | B01AC06";"N02BA - Salicylic acid and derivatives | N02BA - Salicylic acid and derivatives | N02BA - Salicylic acid and derivatives | A01AD - Other agents for local oral treatment | B01AC - Platelet aggregation inhibitors excl. heparin";"N02B - OTHER ANALGESICS AND ANTIPYRETICS | N02B - OTHER ANALGESICS AND ANTIPYRETICS | N02B - OTHER ANALGESICS AND ANTIPYRETICS | A01A - STOMATOLOGICAL PREPARATIONS | B01A - ANTITHROMBOTIC AGENTS";"N02 - ANALGESICS | N02 - ANALGESICS | N02 - ANALGESICS | A01 - STOMATOLOGICAL PREPARATIONS | B01 - ANTITHROMBOTIC AGENTS";"N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | A - ALIMENTARY TRACT AND METABOLISM | B - BLOOD AND BLOOD FORMING ORGANS";"CHEMBL25"
"CHEMBL38827";"LUMEFANTRINE";"Small molecule";"4";"2009";"";"CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1";"Ferriprotoporphyrin IX inhibitor";"";"";"CHEMBL613897";"Ferriprotoporphyrin IX";"INHIBITOR";"SMALL MOLECULE";"Plasmodium falciparum";"";"";"Type: DailyMed RefID: setid=7866ec19-dfac-47d4-a53f-511a12643cbf#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7866ec19-dfac-47d4-a53f-511a12643cbf#nlm34090-1|Type: Wikipedia RefID: Hemin URL: http://en.wikipedia.org/wiki/Hemin";"Lumefantrine (BAN, FDA, INN, JAN, MI, USAN, USP)|";"";"";"";"";"";"CHEMBL38827"
"CHEMBL547";"ISOTRETINOIN";"Small molecule";"4";"1982";"'-retin-'";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1";"Retinoic acid receptor agonist";"Prodrug. RARG/RXRA are predominant forms in skin";"";"CHEMBL2363069";"Retinoic acid receptor";"AGONIST";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: PubMed RefID: 20436884 URL: http://europepmc.org/abstract/MED/20436884";"Isotretinoin (BAN, FDA, INN, MI, USAN, USP)|Retinoic acid 13-cis-form (MI)|";"D10BA01 | D10AD54 | D10AD04";"D10BA - Retinoids for treatment of acne | D10AD - Retinoids for topical use in acne | D10AD - Retinoids for topical use in acne";"D10B - ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE | D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE | D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE";"D10 - ANTI-ACNE PREPARATIONS | D10 - ANTI-ACNE PREPARATIONS | D10 - ANTI-ACNE PREPARATIONS";"D - DERMATOLOGICALS | D - DERMATOLOGICALS | D - DERMATOLOGICALS";"CHEMBL547"
"CHEMBL70927";"DEFERIPRONE";"Small molecule";"4";"1999";"";"Cc1c(O)c(=O)ccn1C";"Unknown";"";"";"";"";"";"";"";"";"";"Type: FDA RefID: label/2012/021825s001lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021825s001lbl.pdf";"Deferiprone (BAN, FDA, INN, MI, USAN)|";"V03AC02";"V03AC - Iron chelating agents";"V03A - ALL OTHER THERAPEUTIC PRODUCTS";"V03 - ALL OTHER THERAPEUTIC PRODUCTS";"V - VARIOUS";"CHEMBL70927"
"CHEMBL1201187";"MARAVIROC";"Small molecule";"4";"2007";"'-vir-; -viroc'";"Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1";"C-C chemokine receptor type 5 antagonist";"";"";"CHEMBL274";"C-C chemokine receptor type 5";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=a94a9a2b-337b-4c13-8622-fc392194dc21 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a94a9a2b-337b-4c13-8622-fc392194dc21";"Maraviroc (FDA, INN, JAN, MI)|";"J05AX09";"J05AX - Other antivirals";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1201187"
"CHEMBL109";"VALPROIC ACID";"Small molecule";"4";"1978";"";"CCCC(CCC)C(=O)O";"Succinate semialdehyde dehydrogenase inhibitor";"";"";"CHEMBL1911";"Succinate semialdehyde dehydrogenase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 10812195 URL: http://europepmc.org/abstract/MED/10812195";"Sodium Valproate (JAN)|Valproate Sodium (FDA, USAN, USP)|Valproic acid sodium salt (1:1) (MI)|Valproic acid (BAN, FDA, INN, MI, USAN, USP)|Divalproex Sodium (FDA, USAN, USP)|Semisodium Valproate (BAN)|Valproate Semisodium (INN)|Valproic acid sodium salt (2:1) (MI)|";"N03AG01";"N03AG - Fatty acid derivatives";"N03A - ANTIEPILEPTICS";"N03 - ANTIEPILEPTICS";"N - NERVOUS SYSTEM";"CHEMBL109"
"CHEMBL64";"ISONIAZID";"Small molecule";"4";"1952";"";"NNC(=O)c1ccncc1";"Enoyl-[acyl-carrier-protein] reductase inhibitor";"";"";"CHEMBL1849";"Enoyl-[acyl-carrier-protein] reductase";"INHIBITOR";"SINGLE PROTEIN";"Mycobacterium tuberculosis";"";"";"Type: PubMed RefID: 15273113 URL: http://europepmc.org/abstract/MED/15273113";"Isoniazid (BAN, FDA, INN, JAN, MI, USP)|";"J04AC51 | J04AC01";"J04AC - Hydrazides | J04AC - Hydrazides";"J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS | J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS";"J04 - ANTIMYCOBACTERIALS | J04 - ANTIMYCOBACTERIALS";"J - ANTIINFECTIVES FOR SYSTEMIC USE | J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL64"
"CHEMBL991";"STAVUDINE";"Small molecule";"4";"1994";"'-vudine'";"Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: FDA RefID: label/2011/020412s038,020413s030lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020412s038,020413s030lbl.pdf";"Sanilvudine (JAN)|Stavudine (BAN, FDA, INN, MI, USAN, USP)|";"J05AF04";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL991"
"CHEMBL1503";"OMEPRAZOLE";"Small molecule";"4";"1989";"'-prazole'";"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1";"Potassium-transporting ATPase inhibitor";"";"";"CHEMBL2095173";"Potassium-transporting ATPase";"INHIBITOR";"PROTEIN COMPLEX";"Homo sapiens";"K-ATPase alpha subunit";"Alpha subunit is likely binding site";"Type: FDA RefID: label/2012/019810s095,022056s011lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019810s095,022056s011lbl.pdf|Type: PubMed RefID: 10411559 URL: http://europepmc.org/abstract/MED/10411559|Type: PubMed RefID: 18925391 URL: http://europepmc.org/abstract/MED/18925391|Type: PubMed RefID: 19120905 URL: http://europepmc.org/abstract/MED/19120905";"Omeprazole Sodium (JAN, USAN)|Omeprazole (BAN, FDA, INN, JAN, MI, USAN, USP)|Omeprazole magnesium (FDA, USAN)|Omeprazole Magnesium (USP)|Omeprazole magnesium salt (MI)|";"A02BC01";"A02BC - Proton pump inhibitors";"A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)";"A02 - DRUGS FOR ACID RELATED DISORDERS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1503"
"CHEMBL1201670";"SARGRAMOSTIM";"Protein";"4";"1991";"'-stim'";"";"Granulocyte-macrophage colony-stimulating factor receptor agonist";"";"";"CHEMBL2364169";"Granulocyte-macrophage colony-stimulating factor receptor";"AGONIST";"PROTEIN COMPLEX";"Homo sapiens";"GMCSF receptor alpha subunit";"Alpha subunit is binding site";"Type: DailyMed RefID: setid=04765fbf-f005-43aa-a628-5cc3d80f91e7 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=04765fbf-f005-43aa-a628-5cc3d80f91e7|Type: PubMed RefID: 18692472 URL: http://europepmc.org/abstract/MED/18692472";"Sargramostim (BAN, FDA, INN, JAN, USAN, USP)|";"L03AA09";"L03AA - Colony stimulating factors";"L03A - IMMUNOSTIMULANTS";"L03 - IMMUNOSTIMULANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1201670"
"CHEMBL569";"PROCAINE";"Small molecule";"4";"1954";"'-caine'";"CCN(CC)CCOC(=O)c1ccc(N)cc1";"Sodium channel alpha subunit blocker";"";"";"CHEMBL2331043";"Sodium channel alpha subunit";"BLOCKER";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: ISBN RefID: 9780702034718 PP. 525 URL: http://www.isbnsearch.org/isbn/9780702034718|Type: PubMed RefID: 2167458 URL: http://europepmc.org/abstract/MED/2167458|Type: PubMed RefID: 8581044 URL: http://europepmc.org/abstract/MED/8581044|Type: PubMed RefID: 9768788 URL: http://europepmc.org/abstract/MED/9768788|Type: Wikipedia RefID: Procaine URL: http://en.wikipedia.org/wiki/Procaine";"Procaine HCl (FDA, JAN, MI, USP)|Procaine (BAN, INN, MI)|";"N01BA52 | S01HA05 | N01BA02 | C05AD05";"N01BA - Esters of aminobenzoic acid | S01HA - Local anesthetics | N01BA - Esters of aminobenzoic acid | C05AD - Local anesthetics";"N01B - ANESTHETICS, LOCAL | S01H - LOCAL ANESTHETICS | N01B - ANESTHETICS, LOCAL | C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE";"N01 - ANESTHETICS | S01 - OPHTHALMOLOGICALS | N01 - ANESTHETICS | C05 - VASOPROTECTIVES";"N - NERVOUS SYSTEM | S - SENSORY ORGANS | N - NERVOUS SYSTEM | C - CARDIOVASCULAR SYSTEM";"CHEMBL569"
"CHEMBL1401";"NITAZOXANIDE";"Small molecule";"4";"2002";"'-oxanide'";"CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1";"Pyruvate:ferredoxin oxidoreductase inhibitor";"";"";"CHEMBL2364026";"Pyruvate:ferredoxin oxidoreductase";"INHIBITOR";"SINGLE PROTEIN";"Cryptosporidium parvum";"";"";"Type: DailyMed RefID: setid=56b1575a-dff4-4c5a-a159-2f858e7a0cb8 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56b1575a-dff4-4c5a-a159-2f858e7a0cb8";"Nitazoxanide (BAN, FDA, INN, MI, USAN, USP)|";"P01AX11";"P01AX - Other agents against amoebiasis and other protozoal diseases";"P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES";"P01 - ANTIPROTOZOALS";"P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS";"CHEMBL1401"
"CHEMBL343448";"ROMIDEPSIN";"Protein";"4";"2009";"'-depsin'";"C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O";"Histone deacetylase inhibitor";"";"";"CHEMBL2093865";"Histone deacetylase";"INHIBITOR";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=03b39d40-90fe-11df-9de6-0002a5d5c51b#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03b39d40-90fe-11df-9de6-0002a5d5c51b#section-13|Type: Wikipedia RefID: Histone_deacetylase_inhibitor URL: http://en.wikipedia.org/wiki/Histone_deacetylase_inhibitor|Type: Wikipedia RefID: Romidepsin URL: http://en.wikipedia.org/wiki/Romidepsin";"Romidepsin (FDA, INN, JAN, MI, USAN)|";"L01XX39";"L01XX - Other antineoplastic agents";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL343448"
"CHEMBL1131";"ACITRETIN";"Small molecule";"4";"1996";"'-retin'";"COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C";"Retinoid receptor agonist";"Precise mechanism uncertain. RARG/RXRA are predominant forms in skin";"";"CHEMBL2363071";"Retinoid receptor";"AGONIST";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: PubMed RefID: 10459139 URL: http://europepmc.org/abstract/MED/10459139|Type: PubMed RefID: 9074840 URL: http://europepmc.org/abstract/MED/9074840|Type: PubMed RefID: 9153406 URL: http://europepmc.org/abstract/MED/9153406";"Acitretin (BAN, FDA, INN, MI, USAN, USP)|";"D05BB02";"D05BB - Retinoids for treatment of psoriasis";"D05B - ANTIPSORIATICS FOR SYSTEMIC USE";"D05 - ANTIPSORIATICS";"D - DERMATOLOGICALS";"CHEMBL1131"
"CHEMBL1389";"LEVONORGESTREL";"Small molecule";"4";"1982";"'-estr-; -gest-'";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC";"Progesterone receptor agonist";"";"";"CHEMBL208";"Progesterone receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 19434887 URL: http://europepmc.org/abstract/MED/19434887|Type: Wikipedia RefID: Levonorgestrel URL: http://en.wikipedia.org/wiki/Levonorgestrel";"Levonorgestrel (BAN, FDA, INN, JAN, USAN, USP)|Norgestrel (-)-form (MI)|";"G03AC03 | G03AD01";"G03AC - Progestogens | G03AD - Emergency contraceptives";"G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE | G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE";"G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL1389"
"CHEMBL1200711";"OMEGA-3-ACID ETHYL ESTERS";"Small molecule";"4";"2004";"'-ster-'";"CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCC.CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC";"Unknown";"Mode of action not fully understood; it seems to increase beta-oxidation, inhibit acyl-CoA:1,2-diacylglycerol acyltransferase (EC 2.3.1.20), decreas lipogenesis in the liver, and increase plasma lipoprotein lipase activity";"";"";"";"";"";"";"";"";"Type: DailyMed RefID: setid=5ada82f0-a5fd-46c9-aecc-f106f614c9f0 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ada82f0-a5fd-46c9-aecc-f106f614c9f0";"Doconexent (Dha Ethyl Ester) (INN)|Icosapent (Epa Ethyl Ester) (INN)|Omega-3 acid ethyl esters (MI)|Omega-3 marine triglycerides (BAN)|Omega-3-Acid Ethyl Esters (FDA, USP)|Omega-3-acid ethyl esters (USAN)|Omega-3-acid ethyl esters type A (FDA)|";"C10AX06";"C10AX - Other lipid modifying agents";"C10A - LIPID MODIFYING AGENTS, PLAIN";"C10 - LIPID MODIFYING AGENTS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL1200711"
"CHEMBL36";"PYRIMETHAMINE";"Small molecule";"4";"1953";"";"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1";"Dihydrofolate reductase inhibitor";"";"";"CHEMBL1939";"Dihydrofolate reductase";"INHIBITOR";"SINGLE PROTEIN";"Plasmodium falciparum K1";"";"";"Type: DailyMed RefID: setid=3e4d5027-7939-480f-ae19-82e764d9fa97 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e4d5027-7939-480f-ae19-82e764d9fa97|Type: Wikipedia RefID: Pyrimethamine URL: http://en.wikipedia.org/wiki/Pyrimethamine";"Pyrimethamine (BAN, FDA, INN, JAN, MI, USP)|";"P01BD01 | P01BD51";"P01BD - Diaminopyrimidines | P01BD - Diaminopyrimidines";"P01B - ANTIMALARIALS | P01B - ANTIMALARIALS";"P01 - ANTIPROTOZOALS | P01 - ANTIPROTOZOALS";"P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS";"CHEMBL36"
"CHEMBL614";"PYRAZINAMIDE";"Small molecule";"4";"1971";"";"NC(=O)c1cnccn1";"Fatty acid synthase inhibitor";"";"";"CHEMBL2011";"Fatty acid synthase";"INHIBITOR";"SINGLE PROTEIN";"Mycobacterium tuberculosis";"";"";"Type: PubMed RefID: 17101678 URL: http://europepmc.org/abstract/MED/17101678|Type: Wikipedia RefID: Pyrazinamide#Mechanism_of_action URL: http://en.wikipedia.org/wiki/Pyrazinamide#Mechanism_of_action";"Pyrazinamide (BAN, FDA, INN, JAN, MI, USP)|";"J04AK01";"J04AK - Other drugs for treatment of tuberculosis";"J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS";"J04 - ANTIMYCOBACTERIALS";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL614"
"CHEMBL231813";"TELAPREVIR";"Protein";"4";"2011";"'-vir'";"CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1";"Hepatitis C virus serine protease, NS3/NS4A inhibitor";"";"";"CHEMBL2095231";"Hepatitis C virus serine protease, NS3/NS4A";"INHIBITOR";"PROTEIN COMPLEX";"Hepatitis C virus";"";"";"Type: FDA RefID: label/2013/201917s010lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/201917s010lbl.pdf";"Telaprevir (FDA, INN, JAN, MI, USAN)|";"J05AP02";"J05AP - Antivirals for treatment of HCV infections";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL231813"
"CHEMBL33";"LEVOFLOXACIN";"Small molecule";"4";"1996";"'-oxacin'";"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23";"DNA gyrase inhibitor";"";"";"CHEMBL2311225";"DNA gyrase";"INHIBITOR";"PROTEIN COMPLEX";"Streptococcus pneumoniae";"";"";"Type: DailyMed RefID: setid=a1f01e8e-97e9-11de-b91d-553856d89593 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1f01e8e-97e9-11de-b91d-553856d89593";"Levofloxacin (BAN, FDA, INN, JAN, USAN, USP)|Levofloxacin hydrate (JAN)|Ofloxacin s-(-)-form (MI)|Ofloxacin s-(-)-form hemihydrate (MI)|";"S01AE05 | J01MA12";"S01AE - Fluoroquinolones | J01MA - Fluoroquinolones";"S01A - ANTIINFECTIVES | J01M - QUINOLONE ANTIBACTERIALS";"S01 - OPHTHALMOLOGICALS | J01 - ANTIBACTERIALS FOR SYSTEMIC USE";"S - SENSORY ORGANS | J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL33"
"CHEMBL503";"LOVASTATIN";"Small molecule";"4";"1987";"'-stat-'";"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"HMG-CoA reductase inhibitor";"";"";"CHEMBL402";"HMG-CoA reductase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=10a557fe-6620-4b15-862a-d3ff5dece612 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10a557fe-6620-4b15-862a-d3ff5dece612";"Lovastatin (BAN, FDA, INN, MI, USAN, USP)|Simvastatin impurity, lovastatin- (USP)|";"C10AA02";"C10AA - HMG CoA reductase inhibitors";"C10A - LIPID MODIFYING AGENTS, PLAIN";"C10 - LIPID MODIFYING AGENTS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL503"
"CHEMBL1241348";"FALDAPREVIR";"Small molecule";"3";"";"'-vir'";"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3csc(NC(=O)C(C)C)n3)nc3c(Br)c(OC)ccc23)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)O";"Hepatitis C virus serine protease, NS3/NS4A inhibitor";"";"";"CHEMBL2095231";"Hepatitis C virus serine protease, NS3/NS4A";"INHIBITOR";"PROTEIN COMPLEX";"Hepatitis C virus";"";"";"Type: PubMed RefID: 20823284 URL: http://europepmc.org/abstract/MED/20823284";"Faldaprevir (INN, USAN)|Faldaprevir sodium (USAN)|";"J05AP04";"J05AP - Antivirals for treatment of HCV infections";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1241348"
"CHEMBL1201565";"EPOETIN ALFA";"Protein";"4";"1989";"'-poetin'";"";"Erythropoietin receptor agonist";"";"";"CHEMBL1817";"Erythropoietin receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2013/103234s5323lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103234s5323lbl.pdf";"Epoetin Alfa (BAN, FDA, INN, USAN)|";"";"";"";"";"";"CHEMBL1201565"
"CHEMBL23";"DILTIAZEM";"Small molecule";"4";"1982";"'-tiazem'";"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1";"Voltage-gated L-type calcium channel blocker";"";"";"CHEMBL2095229";"Voltage-gated L-type calcium channel";"BLOCKER";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=a91f6d42-e74e-461b-af00-44a118ecc502 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a91f6d42-e74e-461b-af00-44a118ecc502|Type: Wikipedia RefID: Calcium_channel_blocker URL: http://en.wikipedia.org/wiki/Calcium_channel_blocker|Type: Wikipedia RefID: Diltiazem URL: http://en.wikipedia.org/wiki/Diltiazem|Type: Wikipedia RefID: L-type_calcium_channel URL: http://en.wikipedia.org/wiki/L-type_calcium_channel|Type: Wikipedia RefID: Voltage-dependent_calcium_channel URL: http://en.wikipedia.org/wiki/Voltage-dependent_calcium_channel";"Diltiazem (BAN, INN, MI)|Diltiazem Malate (FDA, USAN)|Diltiazem HCl (FDA, JAN, MI, USAN, USP)|";"C08DB01 | C05AE03";"C08DB - Benzothiazepine derivatives | C05AE - Muscle relaxants";"C08D - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS | C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE";"C08 - CALCIUM CHANNEL BLOCKERS | C05 - VASOPROTECTIVES";"C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM";"CHEMBL23"
"CHEMBL790";"CHLORHEXIDINE";"Small molecule";"4";"1976";"";"N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1";"Cell membrane inhibitor";"Disrupts cell membrane";"";"CHEMBL2364031";"Cell membrane";"INHIBITOR";"SUBCELLULAR";"Bacteria";"";"";"Type: PubMed RefID: 1335944 URL: http://europepmc.org/abstract/MED/1335944|Type: Wikipedia RefID: Chlorhexidine_gluconate URL: http://en.wikipedia.org/wiki/Chlorhexidine_gluconate";"Chlorhexidine (BAN, INN, MI, USP)|Chlorhexidine d-digluconate (MI)|Chlorhexidine gluconate (FDA, JAN, USAN, USP)|Chlorhexidine Phosphanilate (USAN)|Chlorhexidine HCl (BAN, JAN, USAN)|";"D08AC02 | A01AB03 | S02AA09 | S01AX09 | R02AA05 | D09AA12 | S03AA04 | D08AC52 | B05CA02";"D08AC - Biguanides and amidines | A01AB - Antiinfectives and antiseptics for local oral treatment | S02AA - Antiinfectives | S01AX - Other antiinfectives | R02AA - Antiseptics | D09AA - Medicated dressings with antiinfectives | S03AA - Antiinfectives | D08AC - Biguanides and amidines | B05CA - Antiinfectives";"D08A - ANTISEPTICS AND DISINFECTANTS | A01A - STOMATOLOGICAL PREPARATIONS | S02A - ANTIINFECTIVES | S01A - ANTIINFECTIVES | R02A - THROAT PREPARATIONS | D09A - MEDICATED DRESSINGS | S03A - ANTIINFECTIVES | D08A - ANTISEPTICS AND DISINFECTANTS | B05C - IRRIGATING SOLUTIONS";"D08 - ANTISEPTICS AND DISINFECTANTS | A01 - STOMATOLOGICAL PREPARATIONS | S02 - OTOLOGICALS | S01 - OPHTHALMOLOGICALS | R02 - THROAT PREPARATIONS | D09 - MEDICATED DRESSINGS | S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS | D08 - ANTISEPTICS AND DISINFECTANTS | B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS";"D - DERMATOLOGICALS | A - ALIMENTARY TRACT AND METABOLISM | S - SENSORY ORGANS | S - SENSORY ORGANS | R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS | S - SENSORY ORGANS | D - DERMATOLOGICALS | B - BLOOD AND BLOOD FORMING ORGANS";"CHEMBL790"
"CHEMBL1483";"ALBENDAZOLE";"Small molecule";"4";"1996";"'-bendazole'";"CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1";"Tubulin inhibitor";"";"";"CHEMBL2364704";"Tubulin";"INHIBITOR";"PROTEIN COMPLEX GROUP";"Taeniidae";"Beta tubulin";"Binds to beta tubulin";"Type: DailyMed RefID: setid=e8941166-b77d-45aa-a6e8-04f1c0afd845 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8941166-b77d-45aa-a6e8-04f1c0afd845|Type: ISBN RefID: 9780702034718 PP. 669 URL: http://www.isbnsearch.org/isbn/9780702034718|Type: PubMed RefID: 13678839 URL: http://europepmc.org/abstract/MED/13678839";"Albendazole (BAN, FDA, INN, JAN, MI, USAN, USP)|";"P02CA03";"P02CA - Benzimidazole derivatives";"P02C - ANTINEMATODAL AGENTS";"P02 - ANTHELMINTICS";"P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS";"CHEMBL1483"
"CHEMBL1456";"MYCOPHENOLATE MOFETIL";"Small molecule";"4";"1995";"";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2";"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor";"";"";"CHEMBL2111369";"Inosine-5'-monophosphate dehydrogenase (IMPDH)";"INHIBITOR";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=37241e87-4af4-4dc3-a1aa-ea6f20d8dc40 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=37241e87-4af4-4dc3-a1aa-ea6f20d8dc40|Type: PubMed RefID: 15621150 URL: http://europepmc.org/abstract/MED/15621150|Type: PubMed RefID: 17463174 URL: http://europepmc.org/abstract/MED/17463174|Type: PubMed RefID: 17713475 URL: http://europepmc.org/abstract/MED/17713475";"Mycophenolate Mofetil HCl (FDA, USAN)|Mycophenolate mofetil (FDA, JAN, USAN, USP)|";"";"";"";"";"";"CHEMBL1456"
"CHEMBL112";"ACETAMINOPHEN";"Small molecule";"4";"1968";"";"CC(=O)Nc1ccc(O)cc1";"Anandamide amidohydrolase inhibitor";"FAAH converts acetaminophen into the active metabolite AM404, but this conversion also competes with degradation of anandamide increasing its concentration and effects";"";"CHEMBL2243";"Anandamide amidohydrolase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 15987694 URL: http://europepmc.org/abstract/MED/15987694|Type: Wikipedia RefID: Acetaminophen#Mechanism_of_action URL: http://en.wikipedia.org/wiki/Acetaminophen#Mechanism_of_action";"Acetaminophen (FDA, JAN, MI, USP)|Paracetamol (BAN, DCF, INN)|";"N02BE71 | N02BE51 | N02BE01";"N02BE - Anilides | N02BE - Anilides | N02BE - Anilides";"N02B - OTHER ANALGESICS AND ANTIPYRETICS | N02B - OTHER ANALGESICS AND ANTIPYRETICS | N02B - OTHER ANALGESICS AND ANTIPYRETICS";"N02 - ANALGESICS | N02 - ANALGESICS | N02 - ANALGESICS";"N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM";"CHEMBL112"
"CHEMBL374478";"RIFAMPIN";"Small molecule";"4";"1971";"'-pin; rifa-'";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"Bacterial DNA-directed RNA polymerase inhibitor";"";"";"CHEMBL2364672";"Bacterial DNA-directed RNA polymerase";"INHIBITOR";"PROTEIN COMPLEX";"Bacteria";"RNA polymerase beta/beta prime subunit";"Beta subunit is binding site";"Type: PubMed RefID: 11290327 URL: http://europepmc.org/abstract/MED/11290327|Type: PubMed RefID: 20185278 URL: http://europepmc.org/abstract/MED/20185278|Type: PubMed RefID: 4942761 URL: http://europepmc.org/abstract/MED/4942761|Type: Wikipedia RefID: Rifampin#Mechanism_of_action URL: http://en.wikipedia.org/wiki/Rifampin#Mechanism_of_action";"Rifampicin (BAN, INN, JAN)|Rifampin (FDA, MI, USAN, USP)|Rifamycin amp (MI)|";"J04AB02";"J04AB - Antibiotics";"J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS";"J04 - ANTIMYCOBACTERIALS";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL374478"
"CHEMBL457";"GEMFIBROZIL";"Small molecule";"4";"1981";"";"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1";"Peroxisome proliferator-activated receptor alpha agonist";"";"";"CHEMBL239";"Peroxisome proliferator-activated receptor alpha";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=16a775ec-47e7-491f-8c48-319ce43dcd3b URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16a775ec-47e7-491f-8c48-319ce43dcd3b|Type: Wikipedia RefID: Fibrates URL: http://en.wikipedia.org/wiki/Fibrates|Type: Wikipedia RefID: Gemfibrozil URL: http://en.wikipedia.org/wiki/Gemfibrozil";"Gemfibrozil (BAN, FDA, INN, JAN, MI, USAN, USP)|";"C10AB04";"C10AB - Fibrates";"C10A - LIPID MODIFYING AGENTS, PLAIN";"C10 - LIPID MODIFYING AGENTS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL457"
"CHEMBL90555";"VINCRISTINE";"Small molecule";"4";"1963";"'vin-'";"CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"Tubulin inhibitor";"";"";"CHEMBL2095182";"Tubulin";"INHIBITOR";"PROTEIN COMPLEX GROUP";"Homo sapiens";"Beta tubulin vinca binding domain";"Binds to beta tubulin, vinca site (PMID: 15057285)";"Type: DailyMed RefID: setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9|Type: PubMed RefID: 22044006 URL: http://europepmc.org/abstract/MED/22044006";"Vincristine Sulfate (FDA, JAN, MI, USAN, USP)|Vincristine (BAN, INN, MI)|";"L01CA02";"L01CA - Vinca alkaloids and analogues";"L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL90555"
"CHEMBL3989866";"BICTEGRAVIR";"Small molecule";"4";"2018";"'-vir'";"O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c(O)c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2";"Human immunodeficiency virus type 1 integrase inhibitor";"HIV-1 integrase strand transfer inhibitor|Inhibition of the integrase prevents viral integration into the host DNA which is required for propagation.";"Active against a range of clinical HIV-1 isolates across different groups and subgroups. Also displayed activity against an HIV-2 strain included in the assay (EC50 1.1nM).";"CHEMBL3471";"Human immunodeficiency virus type 1 integrase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"Active site";"Type: FDA RefID: label/2018/210251s000lbl.pdf URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210251s000lbl.pdf";"Bictegravir sodium (FDA, USAN)|Bictegravir (INN, USAN)|";"";"";"";"";"";"CHEMBL3989866"
"CHEMBL593";"DELAVIRDINE";"Small molecule";"4";"1997";"'-vir-'";"CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=992306f0-c612-41dd-a4df-35d1fd360033#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=992306f0-c612-41dd-a4df-35d1fd360033#nlm34090-1";"Delavirdine mesilate (JAN)|Delavirdine mesylate (FDA, USAN)|Delavirdine methanesulfonate (MI)|Delavirdine (INN, MI)|";"J05AG02";"J05AG - Non-nucleoside reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL593"
"CHEMBL403664";"BLEOMYCIN";"Small molecule";"4";"1973";"'-mycin'";"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1";"DNA inhibitor";"";"";"CHEMBL2311221";"DNA";"INHIBITOR";"NUCLEIC-ACID";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=905e0984-2ce3-481c-b1a0-0ef0a616479a URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=905e0984-2ce3-481c-b1a0-0ef0a616479a|Type: Wikipedia RefID: Bleomycin URL: http://en.wikipedia.org/wiki/Bleomycin";"Bleomycin Sulfate (FDA, JAN, USAN, USP)|Bleomycins sulfate (MI)|Bleomycin (INN)|Bleomycin hydrochloride (JAN)|Bleomycins (MI)|";"L01DC01";"L01DC - Other cytotoxic antibiotics";"L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL403664"
"CHEMBL1201564";"INTERFERON GAMMA-1B";"Protein";"4";"1999";"";"";"Interferon gamma receptor agonist";"";"";"CHEMBL2364171";"Interferon gamma receptor";"AGONIST";"PROTEIN COMPLEX";"Homo sapiens";"";"Alpha subunit is binding site";"Type: FDA RefID: label/2015/103836s5182lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103836s5182lbl.pdf|Type: PubMed RefID: 7617032 URL: http://europepmc.org/abstract/MED/7617032";"Interferon .gamma.-1b (MI)|Interferon Gamma-1B (BAN, FDA, INN, MI, USAN)|";"L03AB03";"L03AB - Interferons";"L03A - IMMUNOSTIMULANTS";"L03 - IMMUNOSTIMULANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1201564"
"CHEMBL2109442";"PRO-542";"Antibody";"2";"";"";"";"Envelope glycoprotein gp160 inhibitor";"Blocking its attachment to CD4 cells. Immunoprophyaxis HIV1 infection.";"";"CHEMBL1293311";"Envelope glycoprotein gp160";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: PubMed RefID: 7576908 URL: http://europepmc.org/abstract/MED/7576908";"PRO-542";"";"";"";"";"";"CHEMBL2109442"
"CHEMBL1643";"RIBAVIRIN";"Small molecule";"4";"1985";"'-vir-'";"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1";"Inosine-5'-monophosphate dehydrogenase 1 inhibitor";"";"";"CHEMBL1822";"Inosine-5'-monophosphate dehydrogenase 1";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 16107837 URL: http://europepmc.org/abstract/MED/16107837|Type: Wikipedia RefID: Ribavirin#Mechanisms_of_action URL: http://en.wikipedia.org/wiki/Ribavirin#Mechanisms_of_action";"Ribavirin (FDA, INN, JAN, MI, USAN, USP)|Tribavirin (BAN)|";"J05AP01";"J05AP - Antivirals for treatment of HCV infections";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1643"
"CHEMBL1201558";"INTERFERON ALFA-2B";"Protein";"4";"1986";"";"";"Interferon alpha/beta receptor agonist";"";"";"CHEMBL2364170";"Interferon alpha/beta receptor";"AGONIST";"PROTEIN COMPLEX";"Homo sapiens";"";"Alpha subunit is binding site";"Type: DailyMed RefID: setid=fd653d74-48ab-49e4-a42d-ec1cbc59badb URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd653d74-48ab-49e4-a42d-ec1cbc59badb|Type: PubMed RefID: 10049744 URL: http://europepmc.org/abstract/MED/10049744";"Interferon alfa-2b (BAN, FDA, INN, MI, USAN)|";"L03AB05";"L03AB - Interferons";"L03A - IMMUNOSTIMULANTS";"L03 - IMMUNOSTIMULANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1201558"
"CHEMBL525076";"ENFUVIRTIDE";"Protein";"4";"2003";"'-tide; -vir-'";"CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O";"Transmembrane glycoprotein gp41 inhibitor";"";"";"CHEMBL2362987";"Transmembrane glycoprotein gp41";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus";"";"";"Type: DailyMed RefID: setid=6935e846-d5a1-49e5-89a2-f8ebe4d5590d URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6935e846-d5a1-49e5-89a2-f8ebe4d5590d";"Enfuvirtide (BAN, FDA, INN, MI, USAN)|";"J05AX07";"J05AX - Other antivirals";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL525076"
"CHEMBL704";"MESALAMINE";"Small molecule";"4";"1987";"'-sal-'";"Nc1ccc(O)c(C(=O)O)c1";"Cyclooxygenase inhibitor";"";"";"CHEMBL2094253";"Cyclooxygenase";"INHIBITOR";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: PubMed RefID: 12463455 URL: http://europepmc.org/abstract/MED/12463455|Type: PubMed RefID: 12950415 URL: http://europepmc.org/abstract/MED/12950415|Type: PubMed RefID: 14742690 URL: http://europepmc.org/abstract/MED/14742690";"Mesalamine (FDA, MI, USAN, USP)|Mesalazine (BAN, INN, JAN)|";"A07EC02";"A07EC - Aminosalicylic acid and similar agents";"A07E - INTESTINAL ANTIINFLAMMATORY AGENTS";"A07 - ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL704"
"CHEMBL141";"LAMIVUDINE";"Small molecule";"4";"1995";"'-vudine'";"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1";"DNA inhibitor";"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes";"";"CHEMBL2363047";"DNA";"INHIBITOR";"NUCLEIC-ACID";"Human immunodeficiency virus 2";"";"";"Type: DailyMed RefID: setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e";"Lamivudine (BAN, FDA, INN, JAN, MI, USAN, USP)|";"J05AF05";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL141"
"CHEMBL1200934";"NORGESTIMATE";"Small molecule";"4";"1989";"'-gest-'";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC";"Progesterone receptor agonist";"";"";"CHEMBL208";"Progesterone receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=222f0530-c4b7-47ec-99c9-4ff81eabf485#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=222f0530-c4b7-47ec-99c9-4ff81eabf485#nlm34090-1";"Norgestimate (BAN, FDA, INN, MI, USAN, USP)|";"";"";"";"";"";"CHEMBL1200934"
"CHEMBL1229211";"DOLUTEGRAVIR";"Small molecule";"4";"2013";"'-vir'";"C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N21";"Human immunodeficiency virus type 1 integrase inhibitor";"HIV-1 integrase strand transfer inhibitor";"";"CHEMBL3471";"Human immunodeficiency virus type 1 integrase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: 63df5af3-b8ac-4e76-9830-2dbb340af922 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63df5af3-b8ac-4e76-9830-2dbb340af922|Type: PubMed RefID: 24052331 URL: http://europepmc.org/abstract/MED/24052331";"Dolutegravir Sodium (FDA, USAN)|Dolutegravir (INN, MI, USAN)|";"J05AX12";"J05AX - Other antivirals";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1229211"
"CHEMBL450895";"NYSTATIN";"Small molecule";"4";"1964";"'-stat-'";"C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2";"Ergosterol sequestering agent";"";"";"CHEMBL2364028";"Ergosterol";"SEQUESTERING AGENT";"SMALL MOLECULE";"Candida albicans";"";"";"Type: FDA RefID: anda/98/64142ap_appltr_prntlbl_chemr.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/anda/98/64142ap_appltr_prntlbl_chemr.pdf";"Nystatin (BAN, FDA, INN, JAN, MI, USP)|";"G01AA51 | G01AA01 | D01AA01 | A07AA02";"G01AA - Antibiotics | G01AA - Antibiotics | D01AA - Antibiotics | A07AA - Antibiotics";"G01A - ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS | G01A - ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS | D01A - ANTIFUNGALS FOR TOPICAL USE | A07A - INTESTINAL ANTIINFECTIVES";"G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS | G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS | D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE | A07 - ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS";"G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES | D - DERMATOLOGICALS | A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL450895"
"CHEMBL2103979";"THYMALFASIN";"Protein";"3";"";"";"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(C)=O)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O";"Unknown";"Interaction mechanism poorly understood. N-terminus of thymalfasin interacts with negative regions of membranes due to the exposure of phosphatidylserine. Once N-terminus inserted into the membrane, the rest may interact with nearby proteins acting as effectors and causing a biological signaling cascade. It induces maturation in T-cells and in dendritic cells. Induces gene expression of Toll-like receptors, interleukin (IL-12) and cytokines. Binds to plasma protein albumin (HSA).";"";"";"";"";"";"";"";"";"Type: PubMed RefID: 26909491 URL: http://europepmc.org/abstract/MED/26909491";"Thymalfasin (INN, USAN)|Thymosins thymalfasin (MI)|";"";"";"";"";"";"CHEMBL2103979"
"CHEMBL254316";"RALTEGRAVIR";"Small molecule";"4";"2007";"'-vir'";"Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1";"Human immunodeficiency virus type 1 integrase inhibitor";"";"";"CHEMBL3471";"Human immunodeficiency virus type 1 integrase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=89a5ec53-d956-4329-8004-0f40f51c88a3 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89a5ec53-d956-4329-8004-0f40f51c88a3";"Raltegravir (INN, MI, USAN)|Raltegravir monopotassium salt (MI)|Raltegravir Potassium (FDA, JAN, USAN)|";"J05AX08";"J05AX - Other antivirals";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL254316"
"CHEMBL691";"ETHINYL ESTRADIOL";"Small molecule";"4";"2001";"'estr-'";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C";"Estrogen receptor alpha agonist";"";"";"CHEMBL206";"Estrogen receptor alpha";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: ISBN RefID: 0443-059748 PP. 438 URL: http://www.isbnsearch.org/isbn/0443059748";"Ethinylestradiol (FDA, MI, USP, BAN, INN, JAN)|";"G03CA01 | L02AA03";"G03CA - Natural and semisynthetic estrogens, plain | L02AA - Estrogens";"G03C - ESTROGENS | L02A - HORMONES AND RELATED AGENTS";"G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | L02 - ENDOCRINE THERAPY";"G - GENITO URINARY SYSTEM AND SEX HORMONES | L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL691"
"CHEMBL566534";"ARTEMETHER";"Small molecule";"4";"2009";"'arte-'";"CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3";"Ferriprotoporphyrin IX inhibitor";"prevents crystallisation";"";"CHEMBL613897";"Ferriprotoporphyrin IX";"INHIBITOR";"SMALL MOLECULE";"Plasmodium falciparum";"";"";"Type: DailyMed RefID: setid=7866ec19-dfac-47d4-a53f-511a12643cbf#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7866ec19-dfac-47d4-a53f-511a12643cbf#section-13|Type: Wikipedia RefID: Artemether URL: http://en.wikipedia.org/wiki/Artemether|Type: Wikipedia RefID: Hemozoin URL: http://en.wikipedia.org/wiki/Hemozoin";"Artemether (BAN, FDA, INN, JAN, MI, USAN, USP)|Dihydroartemisinin impurity g (USP)|";"P01BE02";"P01BE - Artemisinin and derivatives, plain";"P01B - ANTIMALARIALS";"P01 - ANTIPROTOZOALS";"P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS";"CHEMBL566534"
"CHEMBL1771";"CLOPIDOGREL";"Small molecule";"4";"1997";"'-grel'";"COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1";"Purinergic receptor P2Y12 antagonist";"Irreversible inhibitor";"";"CHEMBL2001";"Purinergic receptor P2Y12";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=0078fb3d-3595-4ae1-a059-1d5e81c879cf URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0078fb3d-3595-4ae1-a059-1d5e81c879cf";"Clopidogrel Bisulfate (FDA, USAN, USP)|Clopidogrel hydrogen sulfate (MI)|Clopidogrel sulfate (JAN)|Clopidogrel (BAN, INN, MI)|";"B01AC04";"B01AC - Platelet aggregation inhibitors excl. heparin";"B01A - ANTITHROMBOTIC AGENTS";"B01 - ANTITHROMBOTIC AGENTS";"B - BLOOD AND BLOOD FORMING ORGANS";"CHEMBL1771"
"CHEMBL1751";"DIGOXIN";"Small molecule";"4";"1975";"'-oxin'";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"Sodium/potassium-transporting ATPase inhibitor";"";"";"CHEMBL2095186";"Sodium/potassium-transporting ATPase";"INHIBITOR";"PROTEIN COMPLEX GROUP";"Homo sapiens";"K/Na-ATPase alpha subunit";"Alpha subunit is binding site";"Type: DailyMed RefID: setid=8a919762-ede5-4aa9-8688-65010c9a5641 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a919762-ede5-4aa9-8688-65010c9a5641|Type: Wikipedia RefID: Digoxin URL: http://en.wikipedia.org/wiki/Digoxin";"Digoxin (BAN, FDA, INN, JAN, MI, USP)|";"C01AA05";"C01AA - Digitalis glycosides";"C01A - CARDIAC GLYCOSIDES";"C01 - CARDIAC THERAPY";"C - CARDIOVASCULAR SYSTEM";"CHEMBL1751"
"CHEMBL1115";"PYRIDOSTIGMINE";"Small molecule";"4";"1955";"'-stigmine'";"CN(C)C(=O)Oc1ccc[n+](C)c1";"Acetylcholinesterase inhibitor";"";"";"CHEMBL220";"Acetylcholinesterase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=30cb0b9f-e308-4501-90c2-b17349c048b7 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30cb0b9f-e308-4501-90c2-b17349c048b7|Type: Wikipedia RefID: Pyridostigmine#Mode_of_action URL: http://en.wikipedia.org/wiki/Pyridostigmine#Mode_of_action";"Pyridostigmine Bromide (BAN, FDA, INN, JAN, MI, USP)|";"N07AA02";"N07AA - Anticholinesterases";"N07A - PARASYMPATHOMIMETICS";"N07 - OTHER NERVOUS SYSTEM DRUGS";"N - NERVOUS SYSTEM";"CHEMBL1115"
"CHEMBL1064";"SIMVASTATIN";"Small molecule";"4";"1991";"'-stat-'";"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"HMG-CoA reductase inhibitor";"";"";"CHEMBL402";"HMG-CoA reductase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=e9e50cdb-4cef-4d03-9fb6-973d0c2bf293 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9e50cdb-4cef-4d03-9fb6-973d0c2bf293";"Simvastatin (BAN, FDA, INN, JAN, MI, USAN, USP)|";"C10AA01";"C10AA - HMG CoA reductase inhibitors";"C10A - LIPID MODIFYING AGENTS, PLAIN";"C10 - LIPID MODIFYING AGENTS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL1064"
"CHEMBL1789941";"RUXOLITINIB";"Small molecule";"4";"2011";"'-tinib'";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"Tyrosine-protein kinase JAK1 inhibitor";"";"";"CHEMBL2835";"Tyrosine-protein kinase JAK1";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2012/202192s001lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202192s001lbl.pdf";"Ruxolitinib (INN, MI, USAN)|Ruxolitinib Phosphate (FDA, JAN, MI, USAN)|";"L01XE18";"L01XE - Protein kinase inhibitors";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1789941"
"CHEMBL3545347";"TXA127";"Protein";"2";"";"";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)O";"Proto-oncogene Mas agonist";"A pharmaceutical grade formulation of endogenous ligand";"";"CHEMBL3559701";"Proto-oncogene Mas";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 12829792 URL: http://europepmc.org/abstract/MED/12829792";"TXA-127";"";"";"";"";"";"CHEMBL3545347"
"CHEMBL672";"FENOFIBRATE";"Small molecule";"4";"1993";"'-fibrate'";"CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1";"Peroxisome proliferator-activated receptor alpha agonist";"";"";"CHEMBL239";"Peroxisome proliferator-activated receptor alpha";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=24790a18-0291-4b88-a724-acac43b616ce URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24790a18-0291-4b88-a724-acac43b616ce";"Fenofibrate (BAN, FDA, INN, JAN, MI, USAN, USP)|";"C10AB05";"C10AB - Fibrates";"C10A - LIPID MODIFYING AGENTS, PLAIN";"C10 - LIPID MODIFYING AGENTS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL672"
"CHEMBL428647";"PACLITAXEL";"Small molecule";"4";"1992";"'-taxel'";"CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C";"Tubulin inhibitor";"";"";"CHEMBL2095182";"Tubulin";"INHIBITOR";"PROTEIN COMPLEX GROUP";"Homo sapiens";"Beta tubulin paclitaxel binding site";"Binds to beta tubulin";"Type: DailyMed RefID: setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15|Type: Wikipedia RefID: Microtubule URL: http://en.wikipedia.org/wiki/Microtubule";"Paclitaxel (BAN, FDA, INN, JAN, MI, USAN, USP)|";"L01CD01";"L01CD - Taxanes";"L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL428647"
"CHEMBL504";"DIMETHYL SULFOXIDE";"Small molecule";"4";"1978";"";"C[S+](C)[O-]";"Unknown";"";"";"";"";"";"";"";"";"";"Type: PubMed RefID: 17661513 URL: http://europepmc.org/abstract/MED/17661513|Type: PubMed RefID: 3510103 URL: http://europepmc.org/abstract/MED/3510103";"Dimethyl Sulfoxide (BAN, FDA, INN, MI, USAN, USP)|";"M02AX03 | G04BX13";"M02AX - Other topical products for joint and muscular pain | G04BX - Other urologicals";"M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN | G04B - UROLOGICALS";"M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN | G04 - UROLOGICALS";"M - MUSCULO-SKELETAL SYSTEM | G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL504"
"CHEMBL1201570";"ANAKINRA";"Protein";"4";"2001";"'-kinra'";"";"Interleukin-1 receptor antagonist";"";"";"CHEMBL1959";"Interleukin-1 receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=d9d74915-6606-4570-9c52-c4001d3177de URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9d74915-6606-4570-9c52-c4001d3177de";"Anakinra (BAN, FDA, INN, USAN)|";"L04AC03";"L04AC - Interleukin inhibitors";"L04A - IMMUNOSUPPRESSANTS";"L04 - IMMUNOSUPPRESSANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1201570"
"CHEMBL160";"CYCLOSPORINE";"Protein";"4";"1983";"";"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C";"Cyclophilin A modulator";"";"";"CHEMBL1949";"Cyclophilin A";"MODULATOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2013/050573s039,050574s047,050625s053lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050573s039,050574s047,050625s053lbl.pdf|Type: PubMed RefID: 15879096 URL: http://europepmc.org/abstract/MED/15879096|Type: PubMed RefID: 18385230 URL: http://europepmc.org/abstract/MED/18385230|Type: PubMed RefID: 22642569 URL: http://europepmc.org/abstract/MED/22642569";"Ciclosporin (BAN, INN, JAN)|Cyclosporin A (MI)|Cyclosporine (FDA, USAN, USP)|";"S01XA18 | L04AD01";"S01XA - Other ophthalmologicals | L04AD - Calcineurin inhibitors";"S01X - OTHER OPHTHALMOLOGICALS | L04A - IMMUNOSUPPRESSANTS";"S01 - OPHTHALMOLOGICALS | L04 - IMMUNOSUPPRESSANTS";"S - SENSORY ORGANS | L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL160"
"CHEMBL1201334";"TRIPTORELIN";"Protein";"4";"2000";"'-relin'";"CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O";"Gonadotropin-releasing hormone receptor agonist";"";"";"CHEMBL1855";"Gonadotropin-releasing hormone receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=a2f71c34-4493-4d58-9c23-f8543babe95f#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2f71c34-4493-4d58-9c23-f8543babe95f#section-13";"Triptorelin (BAN, INN, MI, USAN)|Triptorelin Pamoate (FDA, MI, USAN)|";"L02AE04";"L02AE - Gonadotropin releasing hormone analogues";"L02A - HORMONES AND RELATED AGENTS";"L02 - ENDOCRINE THERAPY";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1201334"
"CHEMBL114";"SAQUINAVIR";"Small molecule";"4";"1995";"'-vir'";"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1";"Human immunodeficiency virus type 1 protease inhibitor";"";"";"CHEMBL243";"Human immunodeficiency virus type 1 protease";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=c00d1607-ac36-457b-a34b-75ad74f9cf0a URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c00d1607-ac36-457b-a34b-75ad74f9cf0a";"Saquinavir (BAN, FDA, INN, JAN, MI, USAN, USP)|Saquinavir mesilate (JAN)|Saquinavir Mesylate (FDA, USAN, USP)|Saquinavir methanesulfonate salt (MI)|";"J05AE01";"J05AE - Protease inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL114"
"CHEMBL86";"METOCLOPRAMIDE";"Small molecule";"4";"1979";"";"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC";"Dopamine D2 receptor antagonist";"";"";"CHEMBL217";"Dopamine D2 receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2011/017854s058lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017854s058lbl.pdf|Type: Wikipedia RefID: Metoclopramide URL: http://en.wikipedia.org/wiki/Metoclopramide";"Metoclopramide (JAN, BAN, INN, JAN, MI)|Metoclopramide HCl (FDA, JAN, USAN, USP)|";"A03FA01";"A03FA - Propulsives";"A03F - PROPULSIVES";"A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL86"
"CHEMBL717";"MEDROXYPROGESTERONE ACETATE";"Small molecule";"4";"1959";"'-gest-; -ster-'";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"Progesterone receptor agonist";"";"";"CHEMBL208";"Progesterone receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=199cf13e-0859-4a73-9b45-e700d0cd1049#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=199cf13e-0859-4a73-9b45-e700d0cd1049#nlm34090-1";"Medroxyprogesterone (BAN, INN)|Medroxyprogesterone 17-acetate (MI)|Medroxyprogesterone acetate (FDA, JAN, USP)|";"L02AB02 | G03AC06 | G03DA02";"L02AB - Progestogens | G03AC - Progestogens | G03DA - Pregnen (4) derivatives";"L02A - HORMONES AND RELATED AGENTS | G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE | G03D - PROGESTOGENS";"L02 - ENDOCRINE THERAPY | G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL717"
"CHEMBL741";"LAMOTRIGINE";"Small molecule";"4";"1994";"'-trigine'";"Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1";"Sodium channel alpha subunit blocker";"";"";"CHEMBL2331043";"Sodium channel alpha subunit";"BLOCKER";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=d7e3572d-56fe-4727-2bb4-013ccca22678#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7e3572d-56fe-4727-2bb4-013ccca22678#nlm34090-1|Type: PubMed RefID: 15208697 URL: http://europepmc.org/abstract/MED/15208697|Type: PubMed RefID: 23205958 URL: http://europepmc.org/abstract/MED/23205958|Type: PubMed RefID: 23239147 URL: http://europepmc.org/abstract/MED/23239147";"Lamotrigine (BAN, FDA, INN, JAN, MI, USAN, USP)|";"N03AX09";"N03AX - Other antiepileptics";"N03A - ANTIEPILEPTICS";"N03 - ANTIEPILEPTICS";"N - NERVOUS SYSTEM";"CHEMBL741"
"CHEMBL532";"ERYTHROMYCIN";"Small molecule";"4";"1964";"'-mycin'";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"Bacterial 70S ribosome inhibitor";"";"";"CHEMBL2363135";"Bacterial 70S ribosome";"INHIBITOR";"PROTEIN NUCLEIC-ACID COMPLEX";"Bacteria";"23S ribosomal RNA";"23S RRNA";"Type: DailyMed RefID: setid=9a63da11-01be-4c63-a260-e6bdbb4a7a69 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a63da11-01be-4c63-a260-e6bdbb4a7a69|Type: PubMed RefID: 20876130 URL: http://europepmc.org/abstract/MED/20876130";"Erythromycin Lactobionate (BAN, FDA, JAN, MI, USP)|Erythromycin gluceptate (FDA, USP)|Erythromycin Stearate (BAN, FDA, JAN, USP)|Erythromycin (BAN, FDA, INN, JAN, MI, USP)|";"J01FA01 | D10AF02 | S01AA17 | D10AF52";"J01FA - Macrolides | D10AF - Antiinfectives for treatment of acne | S01AA - Antibiotics | D10AF - Antiinfectives for treatment of acne";"J01F - MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS | D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE | S01A - ANTIINFECTIVES | D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE";"J01 - ANTIBACTERIALS FOR SYSTEMIC USE | D10 - ANTI-ACNE PREPARATIONS | S01 - OPHTHALMOLOGICALS | D10 - ANTI-ACNE PREPARATIONS";"J - ANTIINFECTIVES FOR SYSTEMIC USE | D - DERMATOLOGICALS | S - SENSORY ORGANS | D - DERMATOLOGICALS";"CHEMBL532"
"CHEMBL2109341";"CCR5MAB004";"Antibody";"1";"";"";"";"C-C chemokine receptor type 5 inhibitor";"";"";"CHEMBL274";"C-C chemokine receptor type 5";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 18266604 URL: http://europepmc.org/abstract/MED/18266604";"CCR5MAB004";"";"";"";"";"";"CHEMBL2109341"
"CHEMBL1138";"EZETIMIBE";"Small molecule";"4";"2002";"'-imibe'";"O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1";"Niemann-Pick C1-like protein 1 inhibitor";"";"";"CHEMBL2027";"Niemann-Pick C1-like protein 1";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=1396b8b6-651a-4f2f-a2c1-0165173b2eff#section-12 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1396b8b6-651a-4f2f-a2c1-0165173b2eff#section-12";"Ezetimibe (BAN, FDA, INN, JAN, MI, USAN, USP)|";"C10AX09";"C10AX - Other lipid modifying agents";"C10A - LIPID MODIFYING AGENTS, PLAIN";"C10 - LIPID MODIFYING AGENTS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL1138"
"CHEMBL628";"PENTOXIFYLLINE";"Small molecule";"4";"1984";"'-fylline'";"CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O";"3',5'-cyclic phosphodiesterase inhibitor";"";"";"CHEMBL2363066";"3',5'-cyclic phosphodiesterase";"INHIBITOR";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: FDA RefID: label/2012/018631s039lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018631s039lbl.pdf|Type: PubMed RefID: 11692087 URL: http://europepmc.org/abstract/MED/11692087|Type: PubMed RefID: 18568240 URL: http://europepmc.org/abstract/MED/18568240|Type: Wikipedia RefID: Pentoxifylline URL: http://en.wikipedia.org/wiki/Pentoxifylline";"Oxpentifylline (BAN)|Pentoxifylline (BAN, FDA, INN, JAN, MI, USAN, USP)|";"C04AD03";"C04AD - Purine derivatives";"C04A - PERIPHERAL VASODILATORS";"C04 - PERIPHERAL VASODILATORS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL628"
"CHEMBL483254";"PANOBINOSTAT";"Small molecule";"4";"2015";"'-stat'";"Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1";"Histone deacetylase inhibitor";"";"";"CHEMBL2093865";"Histone deacetylase";"INHIBITOR";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: FDA RefID: label/2015/205353s000lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf";"Panobinostat (INN, MI, USAN)|Panobinostat lactate (FDA)|";"L01XX42";"L01XX - Other antineoplastic agents";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL483254"
"CHEMBL1789844";"IPILIMUMAB";"Antibody";"4";"2011";"'-mab'";"";"Cytotoxic T-lymphocyte protein 4 inhibitor";"";"";"CHEMBL2364164";"Cytotoxic T-lymphocyte protein 4";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=2265ef30-253e-11df-8a39-0800200c9a66 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2265ef30-253e-11df-8a39-0800200c9a66";"Ipilimumab (FDA, INN, MI, USAN)|";"L01XC11";"L01XC - Monoclonal antibodies";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1789844"
"CHEMBL223228";"EFAVIRENZ";"Small molecule";"4";"1998";"'-vir-; ef-'";"O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=32d6371e-ba56-4294-b732-6d43627c5c47 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32d6371e-ba56-4294-b732-6d43627c5c47";"Efavirenz (BAN, FDA, INN, JAN, MI, USP)|";"J05AG03";"J05AG - Non-nucleoside reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL223228"
"CHEMBL1098";"BUPIVACAINE";"Small molecule";"4";"1972";"'-caine'";"CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C";"Sodium channel protein type IV alpha subunit blocker";"";"";"CHEMBL2072";"Sodium channel protein type IV alpha subunit";"BLOCKER";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 12761351 URL: http://europepmc.org/abstract/MED/12761351";"Bupivacaine (BAN, FDA, INN, MI, USAN)|Bupivacaine HCl (FDA, JAN, MI, USAN, USP)|Bupivacaine hydrochloride hydrate (JAN)|Bupivacaine hydrochloride monohydrate (MI)|Bupivacaine hydrochloride rs (USP)|";"N01BB51 | N01BB01";"N01BB - Amides | N01BB - Amides";"N01B - ANESTHETICS, LOCAL | N01B - ANESTHETICS, LOCAL";"N01 - ANESTHETICS | N01 - ANESTHETICS";"N - NERVOUS SYSTEM | N - NERVOUS SYSTEM";"CHEMBL1098"
"CHEMBL1460";"DIDANOSINE";"Small molecule";"4";"1991";"";"O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=22e2ca82-c7b5-4f03-9a81-81e130237565 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22e2ca82-c7b5-4f03-9a81-81e130237565";"Didanosine (BAN, FDA, INN, JAN, MI, USAN, USP)|Didanosine system suitability mixture (USP)|";"J05AF02";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1460"
"CHEMBL2110727";"CENICRIVIROC";"Small molecule";"3";"";"'-vir-; -viroc'";"CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1";"C-C chemokine receptor type 5 antagonist";"";"";"CHEMBL274";"C-C chemokine receptor type 5";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 16251299 URL: http://europepmc.org/abstract/MED/16251299|Type: PubMed RefID: 21317794 URL: http://europepmc.org/abstract/MED/21317794|Type: PubMed RefID: 21486960 URL: http://europepmc.org/abstract/MED/21486960";"Cenicriviroc Mesylate (USAN)|Cenicriviroc (INN, USAN)|";"";"";"";"";"";"CHEMBL2110727"
"CHEMBL635";"PREDNISONE";"Small molecule";"4";"1955";"'pred-'";"C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO";"Glucocorticoid receptor agonist";"";"";"CHEMBL2034";"Glucocorticoid receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: ISBN RefID: 978-1-889788-85-2 URL: http://www.isbnsearch.org/isbn/9781889788852|Type: PubMed RefID: 22850902 URL: http://europepmc.org/abstract/MED/22850902|Type: Wikipedia RefID: Glucocorticoid URL: http://en.wikipedia.org/wiki/Glucocorticoid";"Prednisone (BAN, FDA, INN, MI, USP)|Prednisone tablets (USP)|";"H02AB07 | A07EA03";"H02AB - Glucocorticoids | A07EA - Corticosteroids acting locally";"H02A - CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | A07E - INTESTINAL ANTIINFLAMMATORY AGENTS";"H02 - CORTICOSTEROIDS FOR SYSTEMIC USE | A07 - ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS";"H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL635"
"CHEMBL1790041";"RANITIDINE";"Small molecule";"4";"1983";"'-tidine'";"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1";"Histamine H2 receptor antagonist";"";"";"CHEMBL1941";"Histamine H2 receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2009/019090s053,019593s042lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019090s053,019593s042lbl.pdf";"Ranitidine (BAN, FDA, INN, MI, USAN)|Ranitidine HCl (FDA, JAN, MI, USP)|Ranitidine Bismuth Citrate (BAN, FDA, MI, USAN)|Ranitidine Bismutrex (BAN)|";"A02BA02";"A02BA - H2-receptor antagonists";"A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)";"A02 - DRUGS FOR ACID RELATED DISORDERS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1790041"
"CHEMBL182";"GANCICLOVIR";"Small molecule";"4";"1989";"'-vir'";"Nc1nc(O)c2ncn(COC(CO)CO)c2n1";"Human herpesvirus 1 DNA polymerase inhibitor";"";"";"CHEMBL1872";"Human herpesvirus 1 DNA polymerase";"INHIBITOR";"SINGLE PROTEIN";"Herpes simplex virus (type 1 / strain 17)";"";"";"Type: DailyMed RefID: setid=b47f5d1c-36b8-49b6-a410-3b3f4661dde7 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b47f5d1c-36b8-49b6-a410-3b3f4661dde7";"Ganciclovir sodium (FDA, USAN)|Ganciclovir sodium salt (MI)|Ganciclovir (BAN, FDA, INN, JAN, MI, USAN, USP)|";"J05AB06 | S01AD09";"J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors | S01AD - Antivirals";"J05A - DIRECT ACTING ANTIVIRALS | S01A - ANTIINFECTIVES";"J05 - ANTIVIRALS FOR SYSTEMIC USE | S01 - OPHTHALMOLOGICALS";"J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS";"CHEMBL182"
"CHEMBL1431";"METFORMIN";"Small molecule";"4";"1995";"'-formin'";"CN(C)C(=N)NC(=N)N";"Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor";"";"";"CHEMBL3391681";"Mitochondrial glycerol-3-phosphate dehydrogenase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 24847880 URL: http://europepmc.org/abstract/MED/24847880";"Metformin HCl (FDA, JAN, MI, USAN, USP)|Metformin (BAN, INN, MI, USAN)|";"A10BA02";"A10BA - Biguanides";"A10B - BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS";"A10 - DRUGS USED IN DIABETES";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1431"
"CHEMBL1201438";"ALDESLEUKIN";"Protein";"4";"1992";"'-kin'";"";"Interleukin-2 receptor agonist";"";"";"CHEMBL2364167";"Interleukin-2 receptor";"AGONIST";"PROTEIN COMPLEX";"Homo sapiens";"Interleukin-2 alpha/beta subunit";"Binding site involves alpha and beta subunits";"Type: DailyMed RefID: setid=a588140c-f9ed-4a9b-a9a6-bf3daafd8a5a#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a588140c-f9ed-4a9b-a9a6-bf3daafd8a5a#nlm34090-1";"Aldesleukin (BAN, FDA, INN, USAN)|Interleukin-2 aldesleukin (MI)|";"L03AC01";"L03AC - Interleukins";"L03A - IMMUNOSTIMULANTS";"L03 - IMMUNOSTIMULANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1201438"
"CHEMBL141";"LAMIVUDINE";"Small molecule";"4";"1995";"'-vudine'";"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1";"DNA inhibitor";"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes";"";"CHEMBL2363046";"DNA";"INHIBITOR";"NUCLEIC-ACID";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e";"Lamivudine (BAN, FDA, INN, JAN, MI, USAN, USP)|";"J05AF05";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL141"
"CHEMBL294199";"CAPSAICIN";"Small molecule";"4";"2009";"";"COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O";"Vanilloid receptor opener";"";"";"CHEMBL4794";"Vanilloid receptor";"OPENER";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2009/022395lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022395lbl.pdf|Type: Wikipedia RefID: Capsaicin#Mechanism_of_action URL: http://en.wikipedia.org/wiki/Capsaicin#Mechanism_of_action";"Capsaicin (FDA, INN, JAN, MI, USP)|";"N01BX04 | M02AB01";"N01BX - Other local anesthetics | M02AB - Capsaicin and similar agents";"N01B - ANESTHETICS, LOCAL | M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN";"N01 - ANESTHETICS | M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN";"N - NERVOUS SYSTEM | M - MUSCULO-SKELETAL SYSTEM";"CHEMBL294199"
"CHEMBL1029";"MIGLUSTAT";"Small molecule";"4";"2003";"'-stat'";"CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO";"Ceramide glucosyltransferase inhibitor";"";"";"CHEMBL2063";"Ceramide glucosyltransferase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=817892d1-ee12-4632-85fc-57ccdf16d7b8#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=817892d1-ee12-4632-85fc-57ccdf16d7b8#nlm34090-1";"Miglustat (BAN, FDA, INN, JAN, MI, USAN)|";"A16AX06";"A16AX - Various alimentary tract and metabolism products";"A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS";"A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1029"
"CHEMBL222559";"TIPRANAVIR";"Small molecule";"4";"2005";"'-vir'";"CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1";"Human immunodeficiency virus type 1 protease inhibitor";"";"";"CHEMBL243";"Human immunodeficiency virus type 1 protease";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=08982e49-d2eb-4b25-b01a-1be52fd669ef URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08982e49-d2eb-4b25-b01a-1be52fd669ef";"Tipranavir Disodium (USAN)|Tipranavir (BAN, FDA, INN, MI)|";"J05AE09";"J05AE - Protease inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL222559"
"CHEMBL191";"LOSARTAN";"Small molecule";"4";"1995";"'-sartan'";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"Type-1 angiotensin II receptor antagonist";"";"";"CHEMBL227";"Type-1 angiotensin II receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=5ac32c20-169d-475a-fc8a-934f758d6ab0 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ac32c20-169d-475a-fc8a-934f758d6ab0";"Losartan (BAN, INN, MI)|Losartan monopotassium salt (MI)|Losartan potassium (FDA, JAN, USAN, USP)|";"C09CA01";"C09CA - Angiotensin II receptor blockers (ARBs), plain";"C09C - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN";"C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM";"C - CARDIOVASCULAR SYSTEM";"CHEMBL191"
"CHEMBL1201563";"INTERFERON BETA-1B";"Protein";"4";"1993";"";"";"Interferon alpha/beta receptor agonist";"";"";"CHEMBL2364170";"Interferon alpha/beta receptor";"AGONIST";"PROTEIN COMPLEX";"Homo sapiens";"";"Alpha subunit is binding site";"Type: DailyMed RefID: setid=4cfdb571-ec4c-478f-bedc-e0669eeea504 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4cfdb571-ec4c-478f-bedc-e0669eeea504|Type: PubMed RefID: 10049744 URL: http://europepmc.org/abstract/MED/10049744";"Interferon beta-1b (BAN, FDA, INN, MI, USAN)|";"L03AB08";"L03AB - Interferons";"L03A - IMMUNOSTIMULANTS";"L03 - IMMUNOSTIMULANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1201563"
"CHEMBL2109446";"KD-247";"Antibody";"1";"";"";"";"Envelope polyprotein GP160 inhibitor";"";"";"CHEMBL3520";"Envelope polyprotein GP160";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1)";"";"";"Type: Other RefID: http://www.creativebiolabs.net/Anti-HIV-1-gp120-Antibody-24725.htm URL: http://www.creativebiolabs.net/Anti-HIV-1-gp120-Antibody-24725.htm|Type: PubMed RefID: 16699037 URL: http://europepmc.org/abstract/MED/16699037";"KD-247";"";"";"";"";"";"CHEMBL2109446"
"CHEMBL204656";"ELVITEGRAVIR";"Small molecule";"4";"2012";"'-vir'";"COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C";"Human immunodeficiency virus type 1 integrase inhibitor";"HIV-1 integrase strand transfer inhibitor";"";"CHEMBL3471";"Human immunodeficiency virus type 1 integrase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=74ae2a93-b267-444c-8f0f-a2a6522260ee URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74ae2a93-b267-444c-8f0f-a2a6522260ee";"Elvitegravir (FDA, INN, MI, USAN)|";"J05AX11";"J05AX - Other antivirals";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL204656"
"CHEMBL511142";"BUPRENORPHINE";"Small molecule";"4";"1981";"";"CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5";"Kappa opioid receptor agonist";"";"";"CHEMBL237";"Kappa opioid receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=b086772e-d15a-4d13-b1a2-38bfbde1f18c#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b086772e-d15a-4d13-b1a2-38bfbde1f18c#nlm34090-1|Type: PubMed RefID: 18997874 URL: http://europepmc.org/abstract/MED/18997874";"Buprenorphine HCl (FDA, JAN, MI, USAN, USP)|Buprenorphine hydrochloride ciii (USP)|Buprenorphine (BAN, FDA, INN, JAN, MI)|";"N07BC01 | N02AE01 | N07BC51";"N07BC - Drugs used in opioid dependence | N02AE - Oripavine derivatives | N07BC - Drugs used in opioid dependence";"N07B - DRUGS USED IN ADDICTIVE DISORDERS | N02A - OPIOIDS | N07B - DRUGS USED IN ADDICTIVE DISORDERS";"N07 - OTHER NERVOUS SYSTEM DRUGS | N02 - ANALGESICS | N07 - OTHER NERVOUS SYSTEM DRUGS";"N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM";"CHEMBL511142"
"CHEMBL1200680";"SELENIUM SULFIDE";"Small molecule";"4";"1951";"'-ium'";"S=[Se]=S";"Unknown";"";"";"";"";"";"";"";"";"";"Type: DailyMed RefID: setid=7498ba49-9ec8-4057-845b-94e2320870b2 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7498ba49-9ec8-4057-845b-94e2320870b2";"Selenium disulfide (MI)|Selenium Sulfide (FDA, USP)|";"D01AE13";"D01AE - Other antifungals for topical use";"D01A - ANTIFUNGALS FOR TOPICAL USE";"D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE";"D - DERMATOLOGICALS";"CHEMBL1200680"
"CHEMBL704";"MESALAMINE";"Small molecule";"4";"1987";"'-sal-'";"Nc1ccc(O)c(C(=O)O)c1";"Arachidonate 5-lipoxygenase inhibitor";"";"";"CHEMBL215";"Arachidonate 5-lipoxygenase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 2882965 URL: http://europepmc.org/abstract/MED/2882965|Type: PubMed RefID: 6131674 URL: http://europepmc.org/abstract/MED/6131674|Type: PubMed RefID: 6428914 URL: http://europepmc.org/abstract/MED/6428914";"Mesalamine (FDA, MI, USAN, USP)|Mesalazine (BAN, INN, JAN)|";"A07EC02";"A07EC - Aminosalicylic acid and similar agents";"A07E - INTESTINAL ANTIINFLAMMATORY AGENTS";"A07 - ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL704"
"CHEMBL116";"AMPRENAVIR";"Small molecule";"4";"1999";"'-vir'";"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1";"Human immunodeficiency virus type 1 protease inhibitor";"";"";"CHEMBL243";"Human immunodeficiency virus type 1 protease";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: FDA RefID: label/2005/021007s017lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021007s017lbl.pdf";"Amprenavir (BAN, FDA, INN, JAN, MI, USAN)|";"J05AE05";"J05AE - Protease inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL116"
"CHEMBL141";"LAMIVUDINE";"Small molecule";"4";"1995";"'-vudine'";"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e";"Lamivudine (BAN, FDA, INN, JAN, MI, USAN, USP)|";"J05AF05";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL141"
"CHEMBL1469";"PHENYLBUTANOIC ACID";"Small molecule";"4";"1996";"";"O=C(O)CCCc1ccccc1";"Glutamine sequestering agent";"Removes excess nitrogen, caused by enzyme deficiency";"";"CHEMBL2366039";"Glutamine";"SEQUESTERING AGENT";"SMALL MOLECULE";"Homo sapiens";"";"";"Type: FDA RefID: label/2009/020572s016,020573s015lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020572s016,020573s015lbl.pdf|Type: PubMed RefID: 11148549 URL: http://europepmc.org/abstract/MED/11148549";"Sodium phenylbutyrate (BAN, FDA, USAN)|Sodium Phenylbutyrate (JAN, USP)|";"";"";"";"";"";"CHEMBL1469"
"CHEMBL1741";"CLARITHROMYCIN";"Small molecule";"4";"1991";"'-mycin'";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"Bacterial 70S ribosome inhibitor";"";"Broad spectrum";"CHEMBL2363135";"Bacterial 70S ribosome";"INHIBITOR";"PROTEIN NUCLEIC-ACID COMPLEX";"Bacteria";"23S ribosomal RNA";"23S RRNA";"Type: DailyMed RefID: setid=aa44552c-3cfe-4111-8aa5-4251aeed9be9#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa44552c-3cfe-4111-8aa5-4251aeed9be9#nlm34090-1|Type: PubMed RefID: 7683018 URL: http://europepmc.org/abstract/MED/7683018|Type: PubMed RefID: 9425251 URL: http://europepmc.org/abstract/MED/9425251";"Clarithromycin (BAN, FDA, INN, JAN, MI, USAN, USP)|Clarithromycin identity (USP)|";"J01FA09";"J01FA - Macrolides";"J01F - MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS";"J01 - ANTIBACTERIALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1741"
"CHEMBL90593";"PRASTERONE";"Small molecule";"4";"2016";"'-ster-'";"C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CCC2=O";"Unknown";"Not fully established. Prasterone is an inactive endogenous steroid that is converted to active estrogens and androgens. ";"";"";"";"";"";"";"";"";"Type: FDA RefID: label/2016/208470s000lbl.pdf URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208470s000lbl.pdf";"Dehydroepiandrosterone (MI)|Prasterone (FDA, INN, MI, USAN)|";"G03XX01 | A14AA07";"G03XX - Other sex hormones and modulators of the genital system | A14AA - Androstan derivatives";"G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | A14A - ANABOLIC STEROIDS";"G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | A14 - ANABOLIC AGENTS FOR SYSTEMIC USE";"G - GENITO URINARY SYSTEM AND SEX HORMONES | A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL90593"
"CHEMBL468";"THALIDOMIDE";"Small molecule";"4";"1998";"'-domide'";"O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1";"CRL4(CRBN) E3 ubiquitin ligase inhibitor";"";"";"CHEMBL3833061";"CRL4(CRBN) E3 ubiquitin ligase";"INHIBITOR";"PROTEIN COMPLEX";"Homo sapiens";"";"Cereblon";"Type: PubMed RefID: 22552008 URL: http://europepmc.org/abstract/MED/22552008|Type: PubMed RefID: 25043012 URL: http://europepmc.org/abstract/MED/25043012";"Thalidomide (BAN, FDA, INN, JAN, MI, USAN, USP)|";"L04AX02";"L04AX - Other immunosuppressants";"L04A - IMMUNOSUPPRESSANTS";"L04 - IMMUNOSUPPRESSANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL468"
"CHEMBL322241";"TELINAVIR";"Small molecule";"1";"";"'-vir'";"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)C(=O)NC(C)(C)C";"HIV-1 protease inhibitor";"";"";"CHEMBL4296312";"HIV-1 protease";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus";"";"";"Type: Other RefID: https://www.genome.jp/dbget-bin/www_bget?dr:D03842 URL: https://www.genome.jp/dbget-bin/www_bget?dr:D03842|Type: PubMed RefID: 8423599 URL: http://europepmc.org/abstract/MED/8423599|Type: PubMed RefID: 8619573 URL: http://europepmc.org/abstract/MED/8619573";"Telinavir (INN, USAN)|";"";"";"";"";"";"CHEMBL322241"
"CHEMBL667";"ACETYLCHOLINE";"Small molecule";"4";"1973";"";"CC(=O)OCC[N+](C)(C)C";"Muscarinic acetylcholine receptor M3 agonist";"Indicated for miosis, M3 likely involved (main form in iris)";"";"CHEMBL245";"Muscarinic acetylcholine receptor M3";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: ISBN RefID: 9780702034718 PP. 153 URL: http://www.isbnsearch.org/isbn/9780702034718|Type: PubMed RefID: 2912119 URL: http://europepmc.org/abstract/MED/2912119";"Acetylcholine chloride (BAN, FDA, INN, JAN, MI, USP)|Acetylcholine Chloride (JAN)|";"S01EB09";"S01EB - Parasympathomimetics";"S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS";"S01 - OPHTHALMOLOGICALS";"S - SENSORY ORGANS";"CHEMBL667"
"CHEMBL57";"NEVIRAPINE";"Small molecule";"4";"1996";"'-pine; -vir-'";"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=8dfe86aa-ea5d-48d2-94a8-1a5506055d70 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8dfe86aa-ea5d-48d2-94a8-1a5506055d70";"Nevirapine (BAN, FDA, INN, JAN, MI, USAN, USP)|Nevirapine anhydrous (USP)|";"J05AG01";"J05AG - Non-nucleoside reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL57"
"CHEMBL416146";"ETORICOXIB";"Small molecule";"4";"";"'-coxib'";"Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1";"Cyclooxygenase-2 inhibitor";"";"Selectively inhibits COX-2 (IC(50) = 1.1 +/- 0.1microM) compared with COX-1 IC(50)=116 +/- 8 microM.";"CHEMBL230";"Cyclooxygenase-2";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 11160644 URL: http://europepmc.org/abstract/MED/11160644";"Etoricoxib (BAN, INN, MI, USAN, USP)|";"M01AH05";"M01AH - Coxibs";"M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS";"M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS";"M - MUSCULO-SKELETAL SYSTEM";"CHEMBL416146"
"CHEMBL163";"RITONAVIR";"Small molecule";"4";"1996";"'-vir'";"CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1";"Human immunodeficiency virus type 1 protease inhibitor";"";"";"CHEMBL243";"Human immunodeficiency virus type 1 protease";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=13b059c6-0c6c-49a5-b985-a4b05caf9ac9 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13b059c6-0c6c-49a5-b985-a4b05caf9ac9";"Ritonavir (BAN, FDA, INN, JAN, MI, USAN, USP)|Ritonavir related compounds mixture (USP)|";"J05AE03";"J05AE - Protease inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL163"
"CHEMBL1491";"AMLODIPINE";"Small molecule";"4";"1992";"'-dipine'";"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl";"Voltage-gated L-type calcium channel blocker";"";"";"CHEMBL2095229";"Voltage-gated L-type calcium channel";"BLOCKER";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=15416229-d7d3-5bfb-a373-71575c36d5cf#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15416229-d7d3-5bfb-a373-71575c36d5cf#section-13|Type: Wikipedia RefID: Amlodipine URL: http://en.wikipedia.org/wiki/Amlodipine|Type: Wikipedia RefID: Dihydropyridine URL: http://en.wikipedia.org/wiki/Dihydropyridine|Type: Wikipedia RefID: L-type_calcium_channel URL: http://en.wikipedia.org/wiki/L-type_calcium_channel|Type: Wikipedia RefID: Voltage-dependent_calcium_channel URL: http://en.wikipedia.org/wiki/Voltage-dependent_calcium_channel";"Amlodipine benzenesulfonate (MI)|Amlodipine Besilate (JAN)|Amlodipine Besylate (FDA, USAN, USP)|Amlodipine Maleate (FDA, MI, USAN)|Amlodipine (BAN, INN, MI)|";"C08CA01";"C08CA - Dihydropyridine derivatives";"C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS";"C08 - CALCIUM CHANNEL BLOCKERS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL1491"
"CHEMBL704";"MESALAMINE";"Small molecule";"4";"1987";"'-sal-'";"Nc1ccc(O)c(C(=O)O)c1";"Peroxisome proliferator-activated receptor gamma agonist";"";"";"CHEMBL235";"Peroxisome proliferator-activated receptor gamma";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 15824083 URL: http://europepmc.org/abstract/MED/15824083|Type: PubMed RefID: 18077625 URL: http://europepmc.org/abstract/MED/18077625|Type: PubMed RefID: 18544567 URL: http://europepmc.org/abstract/MED/18544567";"Mesalamine (FDA, MI, USAN, USP)|Mesalazine (BAN, INN, JAN)|";"A07EC02";"A07EC - Aminosalicylic acid and similar agents";"A07E - INTESTINAL ANTIINFLAMMATORY AGENTS";"A07 - ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL704"
"CHEMBL1531";"ETONOGESTREL";"Small molecule";"4";"2001";"'-estr-; -gest-'";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC";"Progesterone receptor agonist";"";"";"CHEMBL208";"Progesterone receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: ISBN RefID: 0443-059748 PP. 447 URL: http://www.isbnsearch.org/isbn/0443059748|Type: Wikipedia RefID: Etonogestrel URL: http://en.wikipedia.org/wiki/Etonogestrel";"Etonogestrel (BAN, FDA, INN, USAN)|";"G03AC08";"G03AC - Progestogens";"G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE";"G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL1531"
"CHEMBL1538";"TENOFOVIR DISOPROXIL";"Small molecule";"4";"2001";"'-vir'";"CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=33fd6418-fbdc-42ca-a50d-ce2a476a5418 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33fd6418-fbdc-42ca-a50d-ce2a476a5418";"Tenofovir (BAN, INN)|Tenofovir disoproxil fumarate (FDA, JAN, MI, USAN, USP)|";"J05AF07";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1538"
"CHEMBL1617";"RIFAXIMIN";"Small molecule";"4";"2004";"'rifa-'";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"Bacterial DNA-directed RNA polymerase inhibitor";"";"";"CHEMBL2364672";"Bacterial DNA-directed RNA polymerase";"INHIBITOR";"PROTEIN COMPLEX";"Bacteria";"RNA polymerase beta/beta prime subunit";"Beta subunit is binding site";"Type: DailyMed RefID: setid=523f0320-cc73-445a-a48d-7a181c182307 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=523f0320-cc73-445a-a48d-7a181c182307";"Rifaximin (FDA, INN, JAN, MI, USAN)|";"D06AX11 | A07AA11";"D06AX - Other antibiotics for topical use | A07AA - Antibiotics";"D06A - ANTIBIOTICS FOR TOPICAL USE | A07A - INTESTINAL ANTIINFECTIVES";"D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE | A07 - ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS";"D - DERMATOLOGICALS | A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1617"
"CHEMBL922";"ADEFOVIR DIPIVOXIL";"Small molecule";"4";"2002";"'-vir'";"CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C";"DNA polymerase/reverse transcriptase inhibitor";"";"";"CHEMBL2362994";"DNA polymerase/reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Hepatitis B virus";"";"";"Type: PubMed RefID: 14647052 URL: http://europepmc.org/abstract/MED/14647052|Type: PubMed RefID: 19187868 URL: http://europepmc.org/abstract/MED/19187868";"Adefovir di(pivaloyloxymethyl) ester (MI)|Adefovir dipivoxil (FDA, USAN)|Adefovir pivoxil (JAN)|";"J05AF08";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL922"
"CHEMBL964";"DISULFIRAM";"Small molecule";"4";"1951";"";"CCN(CC)C(=S)SSC(=S)N(CC)CC";"Aldehyde dehydrogenase inhibitor";"";"";"CHEMBL1935";"Aldehyde dehydrogenase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: archiveid=146982 URL: http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=146982|Type: Wikipedia RefID: Disulfiram URL: http://en.wikipedia.org/wiki/Disulfiram";"Disulfiram (BAN, FDA, INN, JAN, MI, USP)|";"N07BB01 | P03AA54 | P03AA04";"N07BB - Drugs used in alcohol dependence | P03AA - Sulfur containing products | P03AA - Sulfur containing products";"N07B - DRUGS USED IN ADDICTIVE DISORDERS | P03A - ECTOPARASITICIDES, INCL. SCABICIDES | P03A - ECTOPARASITICIDES, INCL. SCABICIDES";"N07 - OTHER NERVOUS SYSTEM DRUGS | P03 - ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS | P03 - ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS";"N - NERVOUS SYSTEM | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS";"CHEMBL964"
"CHEMBL628";"PENTOXIFYLLINE";"Small molecule";"4";"1984";"'-fylline'";"CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O";"Adenosine A2 receptor antagonist";"";"";"CHEMBL2094257";"Adenosine A2 receptor";"ANTAGONIST";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: FDA RefID: label/2012/018631s039lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018631s039lbl.pdf|Type: PubMed RefID: 19997047 URL: http://europepmc.org/abstract/MED/19997047|Type: Wikipedia RefID: Pentoxifylline URL: http://en.wikipedia.org/wiki/Pentoxifylline";"Oxpentifylline (BAN)|Pentoxifylline (BAN, FDA, INN, JAN, MI, USAN, USP)|";"C04AD03";"C04AD - Purine derivatives";"C04A - PERIPHERAL VASODILATORS";"C04 - PERIPHERAL VASODILATORS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL628"
"CHEMBL729";"LOPINAVIR";"Small molecule";"4";"2000";"'-vir'";"Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O";"Human immunodeficiency virus type 1 protease inhibitor";"";"";"CHEMBL243";"Human immunodeficiency virus type 1 protease";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: FDA RefID: label/2015/021906s042,021251s049lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021906s042,021251s049lbl.pdf";"Lopinavir (BAN, FDA, INN, JAN, MI, USAN, USP)|";"";"";"";"";"";"CHEMBL729"
"CHEMBL46";"ONDANSETRON";"Small molecule";"4";"1991";"'-setron'";"Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O";"Serotonin 3a (5-HT3a) receptor antagonist";"";"Selective";"CHEMBL1899";"Serotonin 3a (5-HT3a) receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=bb4bc810-db26-471b-9ce7-6e2fb3018af0 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb4bc810-db26-471b-9ce7-6e2fb3018af0";"Ondansetron (BAN, FDA, INN, JAN, MI, USP)|Ondansetron HCl (FDA, JAN, MI, USAN, USP)|Ondansetron hydrochloride dihydrate (MI)|Ondansetron hydrochloride hydrate (JAN)|";"A04AA01";"A04AA - Serotonin (5HT3) antagonists";"A04A - ANTIEMETICS AND ANTINAUSEANTS";"A04 - ANTIEMETICS AND ANTINAUSEANTS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL46"
"CHEMBL19019";"NALTREXONE";"Small molecule";"4";"1984";"'nal-'";"O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5";"Opioid receptors; mu/kappa/delta antagonist";"";"";"CHEMBL2095181";"Opioid receptors; mu/kappa/delta";"ANTAGONIST";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=49aa3d6d-2270-4615-aafa-b440859ab870#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49aa3d6d-2270-4615-aafa-b440859ab870#nlm34090-1";"Naltrexone (BAN, FDA, INN, MI, USAN, USP)|Naltrexone HCl (FDA, MI, USP)|";"N07BB04";"N07BB - Drugs used in alcohol dependence";"N07B - DRUGS USED IN ADDICTIVE DISORDERS";"N07 - OTHER NERVOUS SYSTEM DRUGS";"N - NERVOUS SYSTEM";"CHEMBL19019"
"CHEMBL1323";"DARUNAVIR";"Small molecule";"4";"2006";"'-vir'";"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1";"Human immunodeficiency virus type 1 protease inhibitor";"";"";"CHEMBL243";"Human immunodeficiency virus type 1 protease";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=814301f9-c990-46a5-b481-2879a521a16f URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=814301f9-c990-46a5-b481-2879a521a16f";"Darunavir Ethanolate (FDA)|Darunavir (INN, MI, USAN)|";"J05AE10";"J05AE - Protease inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1323"
"CHEMBL1434";"MINOCYCLINE";"Small molecule";"4";"1971";"'-cycline'";"CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O";"Bacterial 70S ribosome inhibitor";"";"";"CHEMBL2363135";"Bacterial 70S ribosome";"INHIBITOR";"PROTEIN NUCLEIC-ACID COMPLEX";"Bacteria";"16S ribosomal RNA";"16s RRNA";"Type: KEGG RefID: D00850 URL: http://www.kegg.jp/dbget-bin/www_bget?dr:D00850|Type: PubMed RefID: 14723559 URL: http://europepmc.org/abstract/MED/14723559";"Minocycline (BAN, INN, MI, USAN)|Minocycline HCl (FDA, JAN, MI, USP)|";"A01AB23 | J01AA08";"A01AB - Antiinfectives and antiseptics for local oral treatment | J01AA - Tetracyclines";"A01A - STOMATOLOGICAL PREPARATIONS | J01A - TETRACYCLINES";"A01 - STOMATOLOGICAL PREPARATIONS | J01 - ANTIBACTERIALS FOR SYSTEMIC USE";"A - ALIMENTARY TRACT AND METABOLISM | J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1434"
"CHEMBL1664";"FOSAMPRENAVIR";"Small molecule";"4";"2003";"'-vir; fos-'";"CC(C)CN(C[C@@H](OP(=O)(O)O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1";"Human immunodeficiency virus type 1 protease inhibitor";"";"";"CHEMBL243";"Human immunodeficiency virus type 1 protease";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: FDA RefID: label/2015/021548s035,022116s019lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021548s035,022116s019lbl.pdf";"Fosamprenavir Sodium (USAN)|Fosamprenavir (INN, MI)|Fosamprenavir Calcium (FDA, USAN)|Fosamprenavir calcium salt (MI)|";"J05AE07";"J05AE - Protease inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1664"
"CHEMBL184";"ACYCLOVIR";"Small molecule";"4";"1982";"'-vir'";"Nc1nc(O)c2ncn(COCCO)c2n1";"Human herpesvirus 1 DNA polymerase inhibitor";"Prodrug enzyme: Thymidine kinase";"";"CHEMBL1872";"Human herpesvirus 1 DNA polymerase";"INHIBITOR";"SINGLE PROTEIN";"Herpes simplex virus (type 1 / strain 17)";"";"";"Type: FDA RefID: label/2014/022436s004lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022436s004lbl.pdf";"Aciclovir (BAN, INN, JAN)|Acyclovir (FDA, MI, USAN, USP)|Acyclovir sodium (FDA, USAN)|Acyclovir sodium salt (MI)|";"S01AD03 | D06BB53 | D06BB03 | J05AB01";"S01AD - Antivirals | D06BB - Antivirals | D06BB - Antivirals | J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors";"S01A - ANTIINFECTIVES | D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE | D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE | J05A - DIRECT ACTING ANTIVIRALS";"S01 - OPHTHALMOLOGICALS | D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE | D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE | J05 - ANTIVIRALS FOR SYSTEMIC USE";"S - SENSORY ORGANS | D - DERMATOLOGICALS | D - DERMATOLOGICALS | J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL184"
"CHEMBL1401";"NITAZOXANIDE";"Small molecule";"4";"2002";"'-oxanide'";"CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1";"Pyruvate:ferredoxin oxidoreductase inhibitor";"";"";"CHEMBL2364027";"Pyruvate:ferredoxin oxidoreductase";"INHIBITOR";"SINGLE PROTEIN";"Giardia intestinalis";"";"";"Type: DailyMed RefID: setid=56b1575a-dff4-4c5a-a159-2f858e7a0cb8 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56b1575a-dff4-4c5a-a159-2f858e7a0cb8";"Nitazoxanide (BAN, FDA, INN, MI, USAN, USP)|";"P01AX11";"P01AX - Other agents against amoebiasis and other protozoal diseases";"P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES";"P01 - ANTIPROTOZOALS";"P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS";"CHEMBL1401"
"CHEMBL651";"METHADONE";"Small molecule";"4";"1947";"";"CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1";"Mu opioid receptor agonist";"";"";"CHEMBL233";"Mu opioid receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=e6af84de-cbfc-4a3b-bd73-6bcf77337168#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6af84de-cbfc-4a3b-bd73-6bcf77337168#nlm34090-1";"Methadone HCl (FDA, JAN, MI, USP)|Methadone hydrochloride cii (USP)|Methadone (BAN, INN, MI)|";"N07BC02 | N02AC52";"N07BC - Drugs used in opioid dependence | N02AC - Diphenylpropylamine derivatives";"N07B - DRUGS USED IN ADDICTIVE DISORDERS | N02A - OPIOIDS";"N07 - OTHER NERVOUS SYSTEM DRUGS | N02 - ANALGESICS";"N - NERVOUS SYSTEM | N - NERVOUS SYSTEM";"CHEMBL651"
"CHEMBL659";"GALANTAMINE";"Small molecule";"4";"2001";"";"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2";"Acetylcholinesterase inhibitor";"";"";"CHEMBL220";"Acetylcholinesterase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=bbdaf2f2-14e6-45c4-b807-5b22955444b0 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bbdaf2f2-14e6-45c4-b807-5b22955444b0";"Galantamine hydrobromide (FDA, USAN)|Galantamine Hydrobromide (JAN, MI, USP)|Galantamine (BAN, INN, MI, USAN)|";"N06DA04";"N06DA - Anticholinesterases";"N06D - ANTI-DEMENTIA DRUGS";"N06 - PSYCHOANALEPTICS";"N - NERVOUS SYSTEM";"CHEMBL659"
"CHEMBL129";"ZIDOVUDINE";"Small molecule";"4";"1987";"'-vudine'";"Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=6df09f15-b102-431c-adde-d7aeef6f5d84 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6df09f15-b102-431c-adde-d7aeef6f5d84";"Zidovudine (BAN, FDA, INN, JAN, MI, USAN, USP)|";"J05AF01";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL129"
"CHEMBL34259";"METHOTREXATE";"Small molecule";"4";"1953";"'-trexate'";"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1";"Dihydrofolate reductase inhibitor";"";"";"CHEMBL202";"Dihydrofolate reductase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=ec476b11-0b3c-4139-b1eb-a3daa76bc271 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ec476b11-0b3c-4139-b1eb-a3daa76bc271";"Methotrexate (BAN, FDA, INN, JAN, MI, USAN, USP)|R-methotrexate (USP)|Methotrexate Sodium (FDA)|";"L04AX03 | L01BA01";"L04AX - Other immunosuppressants | L01BA - Folic acid analogues";"L04A - IMMUNOSUPPRESSANTS | L01B - ANTIMETABOLITES";"L04 - IMMUNOSUPPRESSANTS | L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL34259"
"CHEMBL4297723";"CEMIPLIMAB";"Antibody";"4";"2018";"'-mab'";"";"Programmed cell death protein 1 inhibitor";"Binds to the T-cell PD-1 receptor preventing it's interaction with the PD-L1 and PD-L2 ligands and removing inhibition of immune response. ";"";"CHEMBL3307223";"Programmed cell death protein 1";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2018/761097s000lbl.pdf URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761097s000lbl.pdf";"Cemiplimab (INN, USAN)|Cemiplimab-rwlc (FDA)|";"";"";"";"";"";"CHEMBL4297723"
"CHEMBL98";"VORINOSTAT";"Small molecule";"4";"2006";"'-stat'";"O=C(CCCCCCC(=O)Nc1ccccc1)NO";"Histone deacetylase 1 inhibitor";"";"";"CHEMBL325";"Histone deacetylase 1";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13";"Vorinostat (FDA, INN, JAN, MI, USAN)|";"L01XX38";"L01XX - Other antineoplastic agents";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL98"
"CHEMBL655";"MIDAZOLAM";"Small molecule";"4";"1985";"";"Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2";"GABA-A receptor; anion channel positive allosteric modulator";"";"";"CHEMBL2093872";"GABA-A receptor; anion channel";"POSITIVE ALLOSTERIC MODULATOR";"PROTEIN COMPLEX GROUP";"Homo sapiens";"Benzodiazepine binding site";"Benzodiazepine site";"Type: ISBN RefID: 9780702034718 PP. 497, 533 URL: http://www.isbnsearch.org/isbn/9780702034718|Type: Wikipedia RefID: Benzodiazepine URL: http://en.wikipedia.org/wiki/Benzodiazepine|Type: Wikipedia RefID: GABAA_receptor URL: http://en.wikipedia.org/wiki/GABAA_receptor|Type: Wikipedia RefID: Midazolam URL: http://en.wikipedia.org/wiki/Midazolam";"Midazolam (BAN, FDA, INN, JAN, MI, USP, JAN)|Midazolam civ (USP)|Midazolam Maleate (USAN)|Midazolam HCl (FDA, MI, USAN)|Midazolam hydrochloride civ (USP)|";"N05CD08";"N05CD - Benzodiazepine derivatives";"N05C - HYPNOTICS AND SEDATIVES";"N05 - PSYCHOLEPTICS";"N - NERVOUS SYSTEM";"CHEMBL655"
"CHEMBL602";"CYSTEAMINE";"Small molecule";"4";"1994";"";"NCCS";"Cystine reducing agent";"";"";"CHEMBL2364039";"Cystine";"REDUCING AGENT";"SMALL MOLECULE";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=b98ee838-ed23-42a9-93b5-72579e490fba#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b98ee838-ed23-42a9-93b5-72579e490fba#nlm34090-1";"Cysteamine (MI, USAN)|Mercaptamine (BAN, DCF, INN)|Cysteamine Bitartrate (FDA, JAN, MI)|Cysteamine HCl (FDA, USAN)|";"A16AA04 | S01XA21";"A16AA - Amino acids and derivatives | S01XA - Other ophthalmologicals";"A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS | S01X - OTHER OPHTHALMOLOGICALS";"A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS | S01 - OPHTHALMOLOGICALS";"A - ALIMENTARY TRACT AND METABOLISM | S - SENSORY ORGANS";"CHEMBL602"
"CHEMBL1163";"ATAZANAVIR";"Small molecule";"4";"2003";"'-vir'";"COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C";"Human immunodeficiency virus type 1 protease inhibitor";"";"";"CHEMBL243";"Human immunodeficiency virus type 1 protease";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=165cff62-b284-4a27-a65d-9ec8a5bfcdd8 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=165cff62-b284-4a27-a65d-9ec8a5bfcdd8";"Atazanavir (BAN, INN, MI)|Atazanavir Sulfate (FDA, JAN, MI, USAN, USP)|";"J05AE08";"J05AE - Protease inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1163"
"CHEMBL44884";"ETHAMBUTOL";"Small molecule";"4";"1967";"";"CC[C@@H](CO)NCCN[C@@H](CC)CO";"Arabinosyltransferase A inhibitor";"";"";"CHEMBL1877";"Arabinosyltransferase A";"INHIBITOR";"SINGLE PROTEIN";"Mycobacterium tuberculosis";"";"";"Type: PubMed RefID: 11854934 URL: http://europepmc.org/abstract/MED/11854934|Type: PubMed RefID: 16127055 URL: http://europepmc.org/abstract/MED/16127055|Type: PubMed RefID: 16595677 URL: http://europepmc.org/abstract/MED/16595677|Type: PubMed RefID: 16641474 URL: http://europepmc.org/abstract/MED/16641474|Type: PubMed RefID: 17630736 URL: http://europepmc.org/abstract/MED/17630736|Type: PubMed RefID: 19596878 URL: http://europepmc.org/abstract/MED/19596878|Type: Wikipedia RefID: Ethambutol_hydrochloride#Mechanism_of_action URL: http://en.wikipedia.org/wiki/Ethambutol_hydrochloride#Mechanism_of_action";"Ethambutol dihydrochloride (MI)|Ethambutol HCl (FDA, JAN, USAN, USP)|Ethambutol (BAN, INN, MI)|";"J04AK02";"J04AK - Other drugs for treatment of tuberculosis";"J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS";"J04 - ANTIMYCOBACTERIALS";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL44884"
"CHEMBL1201798";"SEVELAMER";"Small molecule";"4";"2007";"'-mer'";"C=CCN.ClCC1CO1";"Unknown";"";"";"";"";"";"";"";"";"";"Type: FDA RefID: label/2011/022318s003,022127s008lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022318s003,022127s008lbl.pdf";"Sevelamer Carbonate (FDA, MI, USAN)|Sevelamer (INN, MI)|";"V03AE02";"V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia";"V03A - ALL OTHER THERAPEUTIC PRODUCTS";"V03 - ALL OTHER THERAPEUTIC PRODUCTS";"V - VARIOUS";"CHEMBL1201798"
"CHEMBL33";"LEVOFLOXACIN";"Small molecule";"4";"1996";"'-oxacin'";"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23";"Topoisomerase IV inhibitor";"";"";"CHEMBL2363033";"Topoisomerase IV";"INHIBITOR";"PROTEIN COMPLEX";"Streptococcus pneumoniae";"";"";"Type: DailyMed RefID: setid=a1f01e8e-97e9-11de-b91d-553856d89593 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1f01e8e-97e9-11de-b91d-553856d89593";"Levofloxacin (BAN, FDA, INN, JAN, USAN, USP)|Levofloxacin hydrate (JAN)|Ofloxacin s-(-)-form (MI)|Ofloxacin s-(-)-form hemihydrate (MI)|";"S01AE05 | J01MA12";"S01AE - Fluoroquinolones | J01MA - Fluoroquinolones";"S01A - ANTIINFECTIVES | J01M - QUINOLONE ANTIBACTERIALS";"S01 - OPHTHALMOLOGICALS | J01 - ANTIBACTERIALS FOR SYSTEMIC USE";"S - SENSORY ORGANS | J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL33"
"CHEMBL1487";"ATORVASTATIN";"Small molecule";"4";"1996";"'-stat-'";"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O";"HMG-CoA reductase inhibitor";"";"";"CHEMBL402";"HMG-CoA reductase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ccdb6f3-22c7-5b48-46bc-ce4a4c65eb4d#section-13";"Atorvastatin (BAN, INN, MI)|Atorvastatin Calcium (FDA, USAN, USP)|Atorvastatin calcium hydrate (JAN)|Atorvastatin calcium salt anhydrous (MI)|Atorvastatin calcium salt trihydrate (MI)|";"C10AA05";"C10AA - HMG CoA reductase inhibitors";"C10A - LIPID MODIFYING AGENTS, PLAIN";"C10 - LIPID MODIFYING AGENTS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL1487"
"CHEMBL384467";"DEXAMETHASONE";"Small molecule";"4";"1958";"";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"Glucocorticoid receptor agonist";"";"";"CHEMBL2034";"Glucocorticoid receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 16891588 URL: http://europepmc.org/abstract/MED/16891588|Type: PubMed RefID: 16956592 URL: http://europepmc.org/abstract/MED/16956592|Type: PubMed RefID: 16971495 URL: http://europepmc.org/abstract/MED/16971495";"Dexamethasone (BAN, FDA, INN, JAN, MI, USP)|Dexamethasone Metasulfobenzoate Sodium (JAN)|Dexamethasone Palmitate (JAN)|Dexamethasone Valerate (JAN)|";"H02AB02 | D07XB05 | S01CB01 | D07AB19 | R01AD03 | S02BA06 | C05AA09 | D10AA03 | S01BA01 | R01AD53 | A01AC02 | S03BA01";"H02AB - Glucocorticoids | D07XB - Corticosteroids, moderately potent, other combinations | S01CB - Corticosteroids/antiinfectives/mydriatics in combination | D07AB - Corticosteroids, moderately potent (group II) | R01AD - Corticosteroids | S02BA - Corticosteroids | C05AA - Corticosteroids | D10AA - Corticosteroids, combinations for treatment of acne | S01BA - Corticosteroids, plain | R01AD - Corticosteroids | A01AC - Corticosteroids for local oral treatment | S03BA - Corticosteroids";"H02A - CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | D07X - CORTICOSTEROIDS, OTHER COMBINATIONS | S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION | D07A - CORTICOSTEROIDS, PLAIN | R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE | S02B - CORTICOSTEROIDS | C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE | D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE | S01B - ANTIINFLAMMATORY AGENTS | R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE | A01A - STOMATOLOGICAL PREPARATIONS | S03B - CORTICOSTEROIDS";"H02 - CORTICOSTEROIDS FOR SYSTEMIC USE | D07 - CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS | S01 - OPHTHALMOLOGICALS | D07 - CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS | R01 - NASAL PREPARATIONS | S02 - OTOLOGICALS | C05 - VASOPROTECTIVES | D10 - ANTI-ACNE PREPARATIONS | S01 - OPHTHALMOLOGICALS | R01 - NASAL PREPARATIONS | A01 - STOMATOLOGICAL PREPARATIONS | S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS";"H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | D - DERMATOLOGICALS | S - SENSORY ORGANS | D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM | S - SENSORY ORGANS | C - CARDIOVASCULAR SYSTEM | D - DERMATOLOGICALS | S - SENSORY ORGANS | R - RESPIRATORY SYSTEM | A - ALIMENTARY TRACT AND METABOLISM | S - SENSORY ORGANS";"CHEMBL384467"
"CHEMBL121";"ROSIGLITAZONE";"Small molecule";"4";"1999";"'-glitazone'";"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1";"Peroxisome proliferator-activated receptor gamma agonist";"";"Selective";"CHEMBL235";"Peroxisome proliferator-activated receptor gamma";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=28c31e58-0b27-43e2-bae0-9bbb21420e9f URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28c31e58-0b27-43e2-bae0-9bbb21420e9f";"Rosiglitazone (BAN, INN, MI)|Rosiglitazone maleate (FDA, JAN, MI, USAN)|";"A10BG02";"A10BG - Thiazolidinediones";"A10B - BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS";"A10 - DRUGS USED IN DIABETES";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL121"
"CHEMBL563";"FLURBIPROFEN";"Small molecule";"4";"1986";"'-profen'";"CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1";"Cyclooxygenase inhibitor";"";"";"CHEMBL2094253";"Cyclooxygenase";"INHIBITOR";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: PubMed RefID: 10773011 URL: http://europepmc.org/abstract/MED/10773011|Type: PubMed RefID: 11006278 URL: http://europepmc.org/abstract/MED/11006278|Type: PubMed RefID: 11405284 URL: http://europepmc.org/abstract/MED/11405284|Type: PubMed RefID: 11811354 URL: http://europepmc.org/abstract/MED/11811354|Type: PubMed RefID: 12392782 URL: http://europepmc.org/abstract/MED/12392782|Type: PubMed RefID: 17562170 URL: http://europepmc.org/abstract/MED/17562170";"Flurbiprofen sodium (FDA, USP)|Flurbiprofen (BAN, FDA, INN, JAN, MI, USAN, USP)|";"R02AX01 | M01AE09 | S01BC04 | M02AA19";"R02AX - Other throat preparations | M01AE - Propionic acid derivatives | S01BC - Antiinflammatory agents, non-steroids | M02AA - Antiinflammatory preparations, non-steroids for topical use";"R02A - THROAT PREPARATIONS | M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | S01B - ANTIINFLAMMATORY AGENTS | M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN";"R02 - THROAT PREPARATIONS | M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | S01 - OPHTHALMOLOGICALS | M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN";"R - RESPIRATORY SYSTEM | M - MUSCULO-SKELETAL SYSTEM | S - SENSORY ORGANS | M - MUSCULO-SKELETAL SYSTEM";"CHEMBL563"
"CHEMBL1201772";"PRASUGREL";"Small molecule";"4";"2009";"'-grel'";"CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2";"Purinergic receptor P2Y12 antagonist";"Irreversible inhibitor";"";"CHEMBL2001";"Purinergic receptor P2Y12";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=5fe9c118-c44b-48d7-a142-9668ae3df0c6 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5fe9c118-c44b-48d7-a142-9668ae3df0c6";"Prasugrel HCl (FDA, USAN)|Prasugrel (INN, MI)|";"B01AC22";"B01AC - Platelet aggregation inhibitors excl. heparin";"B01A - ANTITHROMBOTIC AGENTS";"B01 - ANTITHROMBOTIC AGENTS";"B - BLOOD AND BLOOD FORMING ORGANS";"CHEMBL1201772"
"CHEMBL131";"PREDNISOLONE";"Small molecule";"4";"1955";"'pred-'";"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO";"Glucocorticoid receptor agonist";"";"";"CHEMBL2034";"Glucocorticoid receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 19482847 URL: http://europepmc.org/abstract/MED/19482847|Type: PubMed RefID: 2879901 URL: http://europepmc.org/abstract/MED/2879901";"Prednisolone (BAN, FDA, INN, JAN, MI, USP)|";"S02BA03 | H02AB06 | S01BA04 | D07AA03 | R01AD02 | D07XA02 | A07EA01 | R01AD52 | C05AA04 | S01CB02 | S03BA02 | A01AC54";"S02BA - Corticosteroids | H02AB - Glucocorticoids | S01BA - Corticosteroids, plain | D07AA - Corticosteroids, weak (group I) | R01AD - Corticosteroids | D07XA - Corticosteroids, weak, other combinations | A07EA - Corticosteroids acting locally | R01AD - Corticosteroids | C05AA - Corticosteroids | S01CB - Corticosteroids/antiinfectives/mydriatics in combination | S03BA - Corticosteroids | A01AC - Corticosteroids for local oral treatment";"S02B - CORTICOSTEROIDS | H02A - CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | S01B - ANTIINFLAMMATORY AGENTS | D07A - CORTICOSTEROIDS, PLAIN | R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE | D07X - CORTICOSTEROIDS, OTHER COMBINATIONS | A07E - INTESTINAL ANTIINFLAMMATORY AGENTS | R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE | C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE | S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION | S03B - CORTICOSTEROIDS | A01A - STOMATOLOGICAL PREPARATIONS";"S02 - OTOLOGICALS | H02 - CORTICOSTEROIDS FOR SYSTEMIC USE | S01 - OPHTHALMOLOGICALS | D07 - CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS | R01 - NASAL PREPARATIONS | D07 - CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS | A07 - ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS | R01 - NASAL PREPARATIONS | C05 - VASOPROTECTIVES | S01 - OPHTHALMOLOGICALS | S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS | A01 - STOMATOLOGICAL PREPARATIONS";"S - SENSORY ORGANS | H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | S - SENSORY ORGANS | D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS | A - ALIMENTARY TRACT AND METABOLISM | R - RESPIRATORY SYSTEM | C - CARDIOVASCULAR SYSTEM | S - SENSORY ORGANS | S - SENSORY ORGANS | A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL131"
"CHEMBL1351";"CARBOPLATIN";"Small molecule";"4";"1989";"'-platin'";"";"DNA inhibitor";"";"";"CHEMBL2311221";"DNA";"INHIBITOR";"NUCLEIC-ACID";"Homo sapiens";"";"";"Type: FDA RefID: label/2012/077139Orig1s016lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/077139Orig1s016lbl.pdf";"Carboplatin (BAN, FDA, INN, JAN, MI, USAN, USP)|";"L01XA02";"L01XA - Platinum compounds";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1351"
"CHEMBL885";"EMTRICITABINE";"Small molecule";"4";"2003";"'-citabine'";"Nc1nc(=O)n([C@@H]2CS[C@H](CO)O2)cc1F";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=d6599395-3944-44f9-97f2-e0424c6b6a1f URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6599395-3944-44f9-97f2-e0424c6b6a1f";"Emtricitabine (FDA, INN, JAN, MI, USAN, USP)|";"J05AF09";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL885"
"CHEMBL1366";"AURANOFIN";"Small molecule";"4";"1985";"";"";"Unknown";"Mode of action not fully understood; it seems to interact with IKKB, which may play a role in its anti-rheumatic effects";"";"";"";"";"";"";"";"";"Type: PubMed RefID: 12754408 URL: http://europepmc.org/abstract/MED/12754408|Type: PubMed RefID: 17034761 URL: http://europepmc.org/abstract/MED/17034761";"Auranofin (BAN, FDA, INN, JAN, MI, USAN)|";"M01CB03";"M01CB - Gold preparations";"M01C - SPECIFIC ANTIRHEUMATIC AGENTS";"M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS";"M - MUSCULO-SKELETAL SYSTEM";"CHEMBL1366"
"CHEMBL137";"METRONIDAZOLE";"Small molecule";"4";"1963";"'-nidazole'";"Cc1ncc([N+](=O)[O-])n1CCO";"DNA inhibitor";"Generates free radicals causing DNA damage in trichomonas + bacterial species.  In H. Pylori infections the oxygen-insensitive NADPH nitroreductase enzymes responsible for metabolite generation are normally found mutated in resistant strains (PMID: 10960092)";"";"CHEMBL2364041";"DNA";"INHIBITOR";"NUCLEIC-ACID";"Bacteria";"";"";"Type: FDA RefID: label/2011/021806s003lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021806s003lbl.pdf|Type: Wikipedia RefID: Metronidazole#Mechanism_of_action URL: http://en.wikipedia.org/wiki/Metronidazole#Mechanism_of_action";"Metronidazole (BAN, FDA, INN, JAN, MI, USAN, USP)|Metronidazole HCl (FDA, MI, USAN)|";"P01AB01 | A01AB17 | J01XD01 | G01AF01 | P01AB51 | D06BX01";"P01AB - Nitroimidazole derivatives | A01AB - Antiinfectives and antiseptics for local oral treatment | J01XD - Imidazole derivatives | G01AF - Imidazole derivatives | P01AB - Nitroimidazole derivatives | D06BX - Other chemotherapeutics";"P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES | A01A - STOMATOLOGICAL PREPARATIONS | J01X - OTHER ANTIBACTERIALS | G01A - ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS | P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES | D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE";"P01 - ANTIPROTOZOALS | A01 - STOMATOLOGICAL PREPARATIONS | J01 - ANTIBACTERIALS FOR SYSTEMIC USE | G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS | P01 - ANTIPROTOZOALS | D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE";"P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | A - ALIMENTARY TRACT AND METABOLISM | J - ANTIINFECTIVES FOR SYSTEMIC USE | G - GENITO URINARY SYSTEM AND SEX HORMONES | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | D - DERMATOLOGICALS";"CHEMBL137"
"CHEMBL2104987";"TEDUGLUTIDE";"Protein";"4";"2012";"'-tide'";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC";"Glucagon-like peptide 2 receptor agonist";"";"";"CHEMBL5844";"Glucagon-like peptide 2 receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=66b69c1e-b25c-44d3-b5ff-1c1de9a516fa URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=66b69c1e-b25c-44d3-b5ff-1c1de9a516fa";"Teduglutide (BAN, INN, JAN, MI, USAN)|Teduglutide Recombinant (FDA)|";"A16AX08";"A16AX - Various alimentary tract and metabolism products";"A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS";"A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL2104987"
"CHEMBL175691";"RILPIVIRINE";"Small molecule";"4";"2011";"'-vir-'";"Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=03880372-2c68-45c6-a53a-f420c49541d6 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03880372-2c68-45c6-a53a-f420c49541d6";"Rilpivirine HCl (FDA, USAN)|Rilpivirine (INN, MI, USAN)|";"J05AG05";"J05AG - Non-nucleoside reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL175691"
"CHEMBL2107862";"RINTATOLIMOD";"Oligonucleotide";"3";"";"'-imod'";"";"Toll-like receptor 3 agonist";"";"";"CHEMBL1075113";"Toll-like receptor 3";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 11607032 URL: http://europepmc.org/abstract/MED/11607032";"Rintatolimod (INN, MI, USAN)|";"";"";"";"";"";"CHEMBL2107862"
"CHEMBL2109343";"LERONLIMAB";"Antibody";"2";"";"'-mab'";"";"C-C chemokine receptor type 5 antagonist";"Viral-entry inhibitor.";"";"CHEMBL274";"C-C chemokine receptor type 5";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 18771406 URL: http://europepmc.org/abstract/MED/18771406";"Leronlimab (INN, USAN)|";"";"";"";"";"";"CHEMBL2109343"
"CHEMBL465";"DRONABINOL";"Small molecule";"4";"1985";"'-nab-'";"CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21";"Cannabinoid CB1 receptor agonist";"";"";"CHEMBL218";"Cannabinoid CB1 receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=68b4168b-5782-4e68-a25a-5b4e4408dbce#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68b4168b-5782-4e68-a25a-5b4e4408dbce#nlm34090-1|Type: PubMed RefID: 16570099 URL: http://europepmc.org/abstract/MED/16570099";"Dronabinol (FDA, INN, USAN, USP)|";"A04AD10";"A04AD - Other antiemetics";"A04A - ANTIEMETICS AND ANTINAUSEANTS";"A04 - ANTIEMETICS AND ANTINAUSEANTS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL465"
"CHEMBL32";"MOXIFLOXACIN";"Small molecule";"4";"1999";"'-oxacin'";"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12";"Topoisomerase IV inhibitor";"";"Broad spectrum";"CHEMBL2363076";"Topoisomerase IV";"INHIBITOR";"PROTEIN COMPLEX";"Bacteria";"";"";"Type: DailyMed RefID: setid=56b4f979-bf20-4908-9d7c-5536221d77f8 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56b4f979-bf20-4908-9d7c-5536221d77f8";"Moxifloxacin HCl (FDA, JAN, MI, USAN, USP)|Moxifloxacin (BAN, INN, MI)|";"J01MA14 | S01AE07";"J01MA - Fluoroquinolones | S01AE - Fluoroquinolones";"J01M - QUINOLONE ANTIBACTERIALS | S01A - ANTIINFECTIVES";"J01 - ANTIBACTERIALS FOR SYSTEMIC USE | S01 - OPHTHALMOLOGICALS";"J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS";"CHEMBL32"
"CHEMBL206031";"BRECANAVIR";"Small molecule";"2";"";"'-vir'";"Cc1nc(COc2ccc(C[C@H](NC(=O)O[C@H]3CO[C@H]4OCC[C@@H]34)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc4c(c3)OCO4)cc2)cs1";"HIV-1 protease inhibitor";"";"";"CHEMBL4296312";"HIV-1 protease";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus";"";"";"Type: PubMed RefID: 17620375 URL: http://europepmc.org/abstract/MED/17620375|Type: PubMed RefID: 17635930 URL: http://europepmc.org/abstract/MED/17635930";"Brecanavir (INN, USAN)|";"";"";"";"";"";"CHEMBL206031"
"CHEMBL1643";"RIBAVIRIN";"Small molecule";"4";"1985";"'-vir-'";"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1";"Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor";"";"";"CHEMBL5375";"Hepatitis C virus NS5B RNA-dependent RNA polymerase";"INHIBITOR";"SINGLE PROTEIN";"Hepatitis C virus";"";"";"Type: PubMed RefID: 16107837 URL: http://europepmc.org/abstract/MED/16107837|Type: Wikipedia RefID: Ribavirin#Mechanisms_of_action URL: http://en.wikipedia.org/wiki/Ribavirin#Mechanisms_of_action";"Ribavirin (FDA, INN, JAN, MI, USAN, USP)|Tribavirin (BAN)|";"J05AP01";"J05AP - Antivirals for treatment of HCV infections";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1643"
"CHEMBL1789941";"RUXOLITINIB";"Small molecule";"4";"2011";"'-tinib'";"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1";"Tyrosine-protein kinase JAK2 inhibitor";"";"";"CHEMBL2971";"Tyrosine-protein kinase JAK2";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2012/202192s001lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202192s001lbl.pdf";"Ruxolitinib (INN, MI, USAN)|Ruxolitinib Phosphate (FDA, JAN, MI, USAN)|";"L01XE18";"L01XE - Protein kinase inhibitors";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1789941"
"CHEMBL932";"DIPYRIDAMOLE";"Small molecule";"4";"1961";"";"OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1";"Equilibrative nucleoside transporter 1 inhibitor";"";"";"CHEMBL1997";"Equilibrative nucleoside transporter 1";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=ae7585ec-1280-40fe-b888-613b8a0e6ef6 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae7585ec-1280-40fe-b888-613b8a0e6ef6|Type: UniProt RefID: Q99808#section_comments URL: http://www.uniprot.org/uniprot/Q99808#section_comments";"Dipyridamole (BAN, FDA, INN, JAN, MI, USAN, USP)|";"B01AC07";"B01AC - Platelet aggregation inhibitors excl. heparin";"B01A - ANTITHROMBOTIC AGENTS";"B01 - ANTITHROMBOTIC AGENTS";"B - BLOOD AND BLOOD FORMING ORGANS";"CHEMBL932"
"CHEMBL135";"ESTRADIOL";"Small molecule";"4";"1975";"'estr-'";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"Estrogen receptor alpha agonist";"";"";"CHEMBL206";"Estrogen receptor alpha";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=0f943869-41a2-4f7e-943d-dd8c17996dd8#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0f943869-41a2-4f7e-943d-dd8c17996dd8#nlm34090-1|Type: Wikipedia RefID: Estrogen_receptor URL: http://en.wikipedia.org/wiki/Estrogen_receptor";"Estradiol (BAN, FDA, INN, JAN, MI, USP)|Estradiol Hemihydrate (FDA)|";"G03CA03 | G03CA53";"G03CA - Natural and semisynthetic estrogens, plain | G03CA - Natural and semisynthetic estrogens, plain";"G03C - ESTROGENS | G03C - ESTROGENS";"G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL135"
"CHEMBL1201572";"ETANERCEPT";"Protein";"4";"1998";"'-cept'";"";"TNF-alpha inhibitor";"";"";"CHEMBL1825";"TNF-alpha";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=a002b40c-097d-47a5-957f-7a7b1807af7f URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a002b40c-097d-47a5-957f-7a7b1807af7f|Type: PubMed RefID: 10090426 URL: http://europepmc.org/abstract/MED/10090426";"Etanercept (FDA, INN, MI, USAN)|";"L04AB01";"L04AB - Tumor necrosis factor alpha (TNF-alpha) inhibitors";"L04A - IMMUNOSUPPRESSANTS";"L04 - IMMUNOSUPPRESSANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1201572"
"CHEMBL902";"FAMOTIDINE";"Small molecule";"4";"1986";"'-tidine'";"NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1";"Histamine H2 receptor antagonist";"";"";"CHEMBL1941";"Histamine H2 receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=1893ed5d-eddc-49ea-94d0-b839e0b1bfc9 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1893ed5d-eddc-49ea-94d0-b839e0b1bfc9";"Famotidine (BAN, FDA, INN, JAN, MI, USAN, USP)|";"A02BA53 | A02BA03";"A02BA - H2-receptor antagonists | A02BA - H2-receptor antagonists";"A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)";"A02 - DRUGS FOR ACID RELATED DISORDERS | A02 - DRUGS FOR ACID RELATED DISORDERS";"A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL902"
"CHEMBL1536";"ERGOCALCIFEROL";"Small molecule";"4";"1941";"'-calci-'";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C";"Vitamin D receptor agonist";"";"";"CHEMBL1977";"Vitamin D receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 16949927 URL: http://europepmc.org/abstract/MED/16949927|Type: PubMed RefID: 17218095 URL: http://europepmc.org/abstract/MED/17218095|Type: PubMed RefID: 17519354 URL: http://europepmc.org/abstract/MED/17519354";"Ergocalciferol (BAN, FDA, INN, JAN, USP)|Vitamin D2 (MI)|";"A11CC01";"A11CC - Vitamin D and analogues";"A11C - VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO";"A11 - VITAMINS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1536"
"CHEMBL91";"MICONAZOLE";"Small molecule";"4";"1974";"'-conazole'";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"Cytochrome P450 51 inhibitor";"";"";"CHEMBL1780";"Cytochrome P450 51";"INHIBITOR";"SINGLE PROTEIN";"Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)";"";"";"Type: PubMed RefID: 10515900 URL: http://europepmc.org/abstract/MED/10515900|Type: PubMed RefID: 12366848 URL: http://europepmc.org/abstract/MED/12366848|Type: PubMed RefID: 8834867 URL: http://europepmc.org/abstract/MED/8834867|Type: PubMed RefID: 9564569 URL: http://europepmc.org/abstract/MED/9564569|Type: Wikipedia RefID: Miconazole URL: http://en.wikipedia.org/wiki/Miconazole";"Miconazole (BAN, FDA, INN, JAN, MI, USP)|Miconazole nitrate (FDA, JAN, USAN, USP)|Miconazole Nitrate (MI)|";"D01AC02 | A01AB09 | J02AB01 | D01AC52 | A07AC01 | S02AA13 | G01AF04";"D01AC - Imidazole and triazole derivatives | A01AB - Antiinfectives and antiseptics for local oral treatment | J02AB - Imidazole derivatives | D01AC - Imidazole and triazole derivatives | A07AC - Imidazole derivatives | S02AA - Antiinfectives | G01AF - Imidazole derivatives";"D01A - ANTIFUNGALS FOR TOPICAL USE | A01A - STOMATOLOGICAL PREPARATIONS | J02A - ANTIMYCOTICS FOR SYSTEMIC USE | D01A - ANTIFUNGALS FOR TOPICAL USE | A07A - INTESTINAL ANTIINFECTIVES | S02A - ANTIINFECTIVES | G01A - ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS";"D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE | A01 - STOMATOLOGICAL PREPARATIONS | J02 - ANTIMYCOTICS FOR SYSTEMIC USE | D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE | A07 - ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS | S02 - OTOLOGICALS | G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS";"D - DERMATOLOGICALS | A - ALIMENTARY TRACT AND METABOLISM | J - ANTIINFECTIVES FOR SYSTEMIC USE | D - DERMATOLOGICALS | A - ALIMENTARY TRACT AND METABOLISM | S - SENSORY ORGANS | G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL91"
"CHEMBL103";"PROGESTERONE";"Small molecule";"4";"1976";"'-gest-; -ster-'";"CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C";"Progesterone receptor agonist";"";"";"CHEMBL208";"Progesterone receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 10997774 URL: http://europepmc.org/abstract/MED/10997774";"Progesterone (BAN, FDA, INN, JAN, MI, USP)|";"G03DA04";"G03DA - Pregnen (4) derivatives";"G03D - PROGESTOGENS";"G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL103"
"CHEMBL1743087";"VEDOLIZUMAB";"Antibody";"4";"2014";"'-mab'";"";"Integrin alpha-4/beta-7 inhibitor";"";"";"CHEMBL2095184";"Integrin alpha-4/beta-7";"INHIBITOR";"PROTEIN COMPLEX";"Homo sapiens";"";"";"Type: FDA RefID: label/2014/125476s000lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125476s000lbl.pdf";"Vedolizumab (FDA, INN, MI, USAN)|";"L04AA33";"L04AA - Selective immunosuppressants";"L04A - IMMUNOSUPPRESSANTS";"L04 - IMMUNOSUPPRESSANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1743087"
"CHEMBL98";"VORINOSTAT";"Small molecule";"4";"2006";"'-stat'";"O=C(CCCCCCC(=O)Nc1ccccc1)NO";"Histone deacetylase 3 inhibitor";"";"";"CHEMBL1829";"Histone deacetylase 3";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13";"Vorinostat (FDA, INN, JAN, MI, USAN)|";"L01XX38";"L01XX - Other antineoplastic agents";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL98"
"CHEMBL960";"LEFLUNOMIDE";"Small molecule";"4";"1998";"";"Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1";"Dihydroorotate dehydrogenase inhibitor";"";"";"CHEMBL1966";"Dihydroorotate dehydrogenase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=320f63f2-fac3-4aee-aff8-85724e00ef52 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=320f63f2-fac3-4aee-aff8-85724e00ef52";"Leflunomide (BAN, FDA, INN, JAN, MI, USAN, USP)|";"L04AA13";"L04AA - Selective immunosuppressants";"L04A - IMMUNOSUPPRESSANTS";"L04 - IMMUNOSUPPRESSANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL960"
"CHEMBL2108658";"TREMELIMUMAB";"Antibody";"3";"";"'-mab'";"";"Cytotoxic T-lymphocyte protein 4 inhibitor";"Blocks the binding of the antigen-presenting cell ligands B7.1 and B7.2 to CTLA-4, resulting in inhibition of B7-CTLA-4-mediated downregulation of T-cell activation.";"";"CHEMBL2364164";"Cytotoxic T-lymphocyte protein 4";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 22437870 URL: http://europepmc.org/abstract/MED/22437870|Type: PubMed RefID: 27042127 URL: http://europepmc.org/abstract/MED/27042127";"Tremelimumab (INN, USAN)|Tremelimumab (genetical recombination) (JAN)|";"";"";"";"";"";"CHEMBL2108658"
"CHEMBL1431";"METFORMIN";"Small molecule";"4";"1995";"'-formin'";"CN(C)C(=N)NC(=N)N";"Mitochondrial complex I (NADH dehydrogenase) inhibitor";"May not be direct target";"";"CHEMBL2363065";"Mitochondrial complex I (NADH dehydrogenase)";"INHIBITOR";"PROTEIN COMPLEX";"Homo sapiens";"";"";"Type: PubMed RefID: 23277337 URL: http://europepmc.org/abstract/MED/23277337|Type: PubMed RefID: 23358356 URL: http://europepmc.org/abstract/MED/23358356|Type: PubMed RefID: 25017630 URL: http://europepmc.org/abstract/MED/25017630";"Metformin HCl (FDA, JAN, MI, USAN, USP)|Metformin (BAN, INN, MI, USAN)|";"A10BA02";"A10BA - Biguanides";"A10B - BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS";"A10 - DRUGS USED IN DIABETES";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1431"
"CHEMBL1471";"APREPITANT";"Small molecule";"4";"2003";"'-tant'";"C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1";"Neurokinin 1 receptor antagonist";"";"";"CHEMBL249";"Neurokinin 1 receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=696f9e80-9cae-403b-de9e-078343ce4713 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=696f9e80-9cae-403b-de9e-078343ce4713";"Aprepitant (FDA, INN, JAN, MI, USAN, USP)|";"A04AD12";"A04AD - Other antiemetics";"A04A - ANTIEMETICS AND ANTINAUSEANTS";"A04 - ANTIEMETICS AND ANTINAUSEANTS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1471"
"CHEMBL853";"ZALCITABINE";"Small molecule";"4";"1992";"'-citabine'";"Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: FDA RefID: label/2002/20199s16lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20199s16lbl.pdf";"Zalcitabine (BAN, FDA, INN, JAN, MI, USAN, USP)|";"J05AF03";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL853"
"CHEMBL2110727";"CENICRIVIROC";"Small molecule";"3";"";"'-vir-; -viroc'";"CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1";"C-C chemokine receptor type 2 antagonist";"";"";"CHEMBL4015";"C-C chemokine receptor type 2";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 16251299 URL: http://europepmc.org/abstract/MED/16251299|Type: PubMed RefID: 21317794 URL: http://europepmc.org/abstract/MED/21317794|Type: PubMed RefID: 21486960 URL: http://europepmc.org/abstract/MED/21486960";"Cenicriviroc Mesylate (USAN)|Cenicriviroc (INN, USAN)|";"";"";"";"";"";"CHEMBL2110727"
"CHEMBL108";"CARBAMAZEPINE";"Small molecule";"4";"1968";"'-pine'";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"Sodium channel alpha subunit blocker";"";"";"CHEMBL2331043";"Sodium channel alpha subunit";"BLOCKER";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: PubMed RefID: 15208697 URL: http://europepmc.org/abstract/MED/15208697|Type: PubMed RefID: 23205958 URL: http://europepmc.org/abstract/MED/23205958";"Carbamazepine (BAN, FDA, INN, JAN, MI, USAN, USP)|";"N03AF01";"N03AF - Carboxamide derivatives";"N03A - ANTIEPILEPTICS";"N03 - ANTIEPILEPTICS";"N - NERVOUS SYSTEM";"CHEMBL108"
"CHEMBL1201621";"SOMATROPIN";"Protein";"4";"1976";"'-pin; -trop-; som-'";"";"Growth hormone receptor agonist";"It's a recombinant protein approved for the treatment of growth hormone deficiency";"";"CHEMBL1976";"Growth hormone receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=ffebf88b-d257-4542-9808-74d9b7167765 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ffebf88b-d257-4542-9808-74d9b7167765|Type: ISBN RefID: 9780702034718 PP. 396 URL: http://www.isbnsearch.org/isbn/9780702034718";"Somatotropin human growth hormone (MI)|Somatropin (BAN, FDA, INN, JAN, USAN, USP)|Somatropin Recombinant (FDA)|";"H01AC01";"H01AC - Somatropin and somatropin agonists";"H01A - ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES";"H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES";"H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS";"CHEMBL1201621"
"CHEMBL115";"INDINAVIR";"Small molecule";"4";"1996";"'-vir'";"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O";"Human immunodeficiency virus type 1 protease inhibitor";"";"";"CHEMBL243";"Human immunodeficiency virus type 1 protease";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f";"Indinavir sulfate (FDA, MI, USAN, USP)|Indinavir sulfate ethanolate (JAN)|Indinavir (BAN, INN, MI, USAN)|Indinavir system suitability (USP)|";"J05AE02";"J05AE - Protease inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL115"
"CHEMBL98";"VORINOSTAT";"Small molecule";"4";"2006";"'-stat'";"O=C(CCCCCCC(=O)Nc1ccccc1)NO";"Histone deacetylase 6 inhibitor";"";"";"CHEMBL1865";"Histone deacetylase 6";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13";"Vorinostat (FDA, INN, JAN, MI, USAN)|";"L01XX38";"L01XX - Other antineoplastic agents";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL98"
"CHEMBL86";"METOCLOPRAMIDE";"Small molecule";"4";"1979";"";"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC";"Serotonin 3a (5-HT3a) receptor antagonist";"";"";"CHEMBL1899";"Serotonin 3a (5-HT3a) receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: ISBN RefID: 0443-059748 PP. 379 URL: http://www.isbnsearch.org/isbn/0443059748|Type: Wikipedia RefID: Metoclopramide URL: http://en.wikipedia.org/wiki/Metoclopramide";"Metoclopramide (JAN, BAN, INN, JAN, MI)|Metoclopramide HCl (FDA, JAN, USAN, USP)|";"A03FA01";"A03FA - Propulsives";"A03F - PROPULSIVES";"A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL86"
"CHEMBL141";"LAMIVUDINE";"Small molecule";"4";"1995";"'-vudine'";"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1";"DNA polymerase/reverse transcriptase inhibitor";"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes";"";"CHEMBL2362994";"DNA polymerase/reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Hepatitis B virus";"";"";"Type: DailyMed RefID: setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e";"Lamivudine (BAN, FDA, INN, JAN, MI, USAN, USP)|";"J05AF05";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL141"
"CHEMBL104";"CLOTRIMAZOLE";"Small molecule";"4";"1975";"";"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1";"Cytochrome P450 51 inhibitor";"Has also been implicated as a therapy for sickle cell anemia, by inhibiting the gardos channel, causing dehydration of the cells (PMID: 8636434)";"";"CHEMBL1780";"Cytochrome P450 51";"INHIBITOR";"SINGLE PROTEIN";"Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)";"";"";"Type: PubMed RefID: 1929324 URL: http://europepmc.org/abstract/MED/1929324|Type: PubMed RefID: 9326581 URL: http://europepmc.org/abstract/MED/9326581";"Clotrimazole (BAN, FDA, INN, JAN, MI, USAN, USP)|";"A01AB18 | G01AF02 | D01AC01";"A01AB - Antiinfectives and antiseptics for local oral treatment | G01AF - Imidazole derivatives | D01AC - Imidazole and triazole derivatives";"A01A - STOMATOLOGICAL PREPARATIONS | G01A - ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS | D01A - ANTIFUNGALS FOR TOPICAL USE";"A01 - STOMATOLOGICAL PREPARATIONS | G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS | D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE";"A - ALIMENTARY TRACT AND METABOLISM | G - GENITO URINARY SYSTEM AND SEX HORMONES | D - DERMATOLOGICALS";"CHEMBL104"
"CHEMBL1496";"ROSUVASTATIN";"Small molecule";"4";"2003";"'-stat-'";"CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O";"HMG-CoA reductase inhibitor";"";"";"CHEMBL402";"HMG-CoA reductase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=e498b80d-7177-4f9d-8471-2e8f913196af URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e498b80d-7177-4f9d-8471-2e8f913196af";"Rosuvastatin (BAN, INN, MI)|Rosuvastatin Calcium (FDA, JAN, USAN)|Rosuvastatin calcium salt (MI)|";"C10AA07";"C10AA - HMG CoA reductase inhibitors";"C10A - LIPID MODIFYING AGENTS, PLAIN";"C10 - LIPID MODIFYING AGENTS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL1496"
"CHEMBL1201605";"DACLIZUMAB";"Antibody";"4";"1997";"'-mab'";"";"Interleukin-2 receptor inhibitor";"";"";"CHEMBL2364167";"Interleukin-2 receptor";"INHIBITOR";"PROTEIN COMPLEX";"Homo sapiens";"Interleukin-2 alpha subunit";"Alpha subunit is binding site";"Type: DailyMed RefID: archiveid=26085 URL: http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=26085|Type: FDA RefID: label/2005/103749s5059lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/103749s5059lbl.pdf";"Daclizumab (BAN, FDA, INN, MI, USAN)|Daclizumab beta (INN)|";"L04AC01";"L04AC - Interleukin inhibitors";"L04A - IMMUNOSUPPRESSANTS";"L04 - IMMUNOSUPPRESSANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1201605"
"CHEMBL2107825";"TENOFOVIR ALAFENAMIDE";"Small molecule";"4";"2015";"'-vir'";"CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"Prodrug of tenofovir; active metabolite tenofovir diphosphate";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: FDA RefID: label/2018/210251s000lbl.pdf URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210251s000lbl.pdf";"Tenofovir alafenamide fumarate (FDA, JAN)|Tenofovir Alafenamide Fumarate (USAN)|Tenofovir Alafenamide (INN, USAN)|";"J05AF13";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL2107825"
"CHEMBL1201821";"PALIFERMIN";"Protein";"4";"2005";"'-ermin'";"";"Fibroblast growth factor receptor 2 agonist";"";"";"CHEMBL4142";"Fibroblast growth factor receptor 2";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2013/125103s146lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125103s146lbl.pdf|Type: PubMed RefID: 16597617 URL: http://europepmc.org/abstract/MED/16597617";"Palifermin (FDA, INN, MI, USAN)|";"V03AF08";"V03AF - Detoxifying agents for antineoplastic treatment";"V03A - ALL OTHER THERAPEUTIC PRODUCTS";"V03 - ALL OTHER THERAPEUTIC PRODUCTS";"V - VARIOUS";"CHEMBL1201821"
"CHEMBL308954";"ETRAVIRINE";"Small molecule";"4";"2008";"'-vir-'";"Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=6a9cbc29-9f15-4b24-8d86-206b82887f3d URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a9cbc29-9f15-4b24-8d86-206b82887f3d";"Etravirine (FDA, INN, JAN, MI, USAN)|";"J05AG04";"J05AG - Non-nucleoside reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL308954"
"CHEMBL638";"VORICONAZOLE";"Small molecule";"4";"2002";"'-conazole'";"C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F";"Cytochrome P450 51 inhibitor";"";"";"CHEMBL1780";"Cytochrome P450 51";"INHIBITOR";"SINGLE PROTEIN";"Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)";"";"";"Type: DailyMed RefID: setid=dac26bcd-7a59-401f-9f66-a0649767cece URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dac26bcd-7a59-401f-9f66-a0649767cece";"Voriconazole (BAN, FDA, INN, JAN, MI, USAN, USP)|";"J02AC03";"J02AC - Triazole derivatives";"J02A - ANTIMYCOTICS FOR SYSTEMIC USE";"J02 - ANTIMYCOTICS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL638"
"CHEMBL1200706";"ALUMINUM HYDROXIDE";"Small molecule";"4";"1983";"";"[Al+3].[OH-].[OH-].[OH-]";"Unknown";"";"";"";"";"";"";"";"";"";"";"Algeldrate (INN, USAN)|Almagate (BAN, INN, USAN)|Aluminum hydroxide (FDA, MI, USP)|Dried aluminum hydroxide gel (USP)|";"A02AB01";"A02AB - Aluminium compounds";"A02A - ANTACIDS";"A02 - DRUGS FOR ACID RELATED DISORDERS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1200706"
"CHEMBL1042";"CHOLECALCIFEROL";"Small molecule";"4";"1999";"'-calci-'";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C";"Vitamin D receptor agonist";"";"";"CHEMBL1977";"Vitamin D receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 15503649 URL: http://europepmc.org/abstract/MED/15503649|Type: PubMed RefID: 20435140 URL: http://europepmc.org/abstract/MED/20435140";"Cholecalciferol (BAN, FDA, JAN, USP)|Colecalciferol (BAN, INN)|Vitamin d assay system suitability (USP)|Vitamin d3 (MI)|";"A11CC05";"A11CC - Vitamin D and analogues";"A11C - VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO";"A11 - VITAMINS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1042"
"CHEMBL459265";"HEXAMETHYL PARAROSANILINE";"Small molecule";"4";"1982";"";"CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1";"DNA inhibitor";"Generates free radicals causing DNA damage.";"";"CHEMBL2364041";"DNA";"INHIBITOR";"NUCLEIC-ACID";"Bacteria";"";"";"Type: PubMed RefID: 2272286 URL: http://europepmc.org/abstract/MED/2272286|Type: PubMed RefID: 3150994 URL: http://europepmc.org/abstract/MED/3150994";"Gentian Violet (FDA, MI, USP)|Methylrosanilinium Chloride (INN, JAN)|";"";"";"";"";"";"CHEMBL459265"
"CHEMBL614";"PYRAZINAMIDE";"Small molecule";"4";"1971";"";"NC(=O)c1cnccn1";"70S ribosome inhibitor";"";"";"CHEMBL2363965";"70S ribosome";"INHIBITOR";"PROTEIN NUCLEIC-ACID COMPLEX";"Mycobacterium tuberculosis";"30S ribosomal protein S1";"30S ribosomal protein S1";"Type: PubMed RefID: 21835980 URL: http://europepmc.org/abstract/MED/21835980|Type: Wikipedia RefID: Pyrazinamide#Mechanism_of_action URL: http://en.wikipedia.org/wiki/Pyrazinamide#Mechanism_of_action";"Pyrazinamide (BAN, FDA, INN, JAN, MI, USP)|";"J04AK01";"J04AK - Other drugs for treatment of tuberculosis";"J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS";"J04 - ANTIMYCOBACTERIALS";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL614"
"CHEMBL568";"OXAZEPAM";"Small molecule";"4";"1965";"'-azepam'";"O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O";"GABA-A receptor; anion channel positive allosteric modulator";"";"";"CHEMBL2093872";"GABA-A receptor; anion channel";"POSITIVE ALLOSTERIC MODULATOR";"PROTEIN COMPLEX GROUP";"Homo sapiens";"Benzodiazepine binding site";"Benzodiazepine site";"Type: PubMed RefID: 2570451 URL: http://europepmc.org/abstract/MED/2570451|Type: PubMed RefID: 6135616 URL: http://europepmc.org/abstract/MED/6135616|Type: Wikipedia RefID: Oxazepam URL: http://en.wikipedia.org/wiki/Oxazepam";"Oxazepam (BAN, FDA, INN, JAN, MI, USAN, USP)|Oxazepam civ (USP)|Temazepam impurity, oxazepam- (USP)|";"N05BA04";"N05BA - Benzodiazepine derivatives";"N05B - ANXIOLYTICS";"N05 - PSYCHOLEPTICS";"N - NERVOUS SYSTEM";"CHEMBL568"
"CHEMBL1255794";"APLAVIROC";"Small molecule";"3";"";"'-vir-; -viroc'";"CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2";"C-C chemokine receptor type 5 antagonist";"Discontinueddue to liver toxicity concerns.";"";"CHEMBL274";"C-C chemokine receptor type 5";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 15280474 URL: http://europepmc.org/abstract/MED/15280474|Type: PubMed RefID: 18378711 URL: http://europepmc.org/abstract/MED/18378711";"Aplaviroc (INN)|Aplaviroc HCl (MI, USAN)|";"";"";"";"";"";"CHEMBL1255794"
"CHEMBL2109562";"CAL";"Antibody";"2";"";"";"";"Parathyroid hormone-related protein inhibitor";"";"";"CHEMBL3712869";"Parathyroid hormone-related protein";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=38505 URL: https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=38505";"CAL";"";"";"";"";"";"CHEMBL2109562"
"CHEMBL1349";"VALACYCLOVIR";"Small molecule";"4";"1995";"'-vir'";"CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21";"Human herpesvirus 1 DNA polymerase inhibitor";"";"";"CHEMBL1872";"Human herpesvirus 1 DNA polymerase";"INHIBITOR";"SINGLE PROTEIN";"Herpes simplex virus (type 1 / strain 17)";"";"";"Type: FDA RefID: label/2010/020487s016lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020487s016lbl.pdf";"Valaciclovir hydrochloride (JAN)|Valacyclovir HCl (FDA, MI, USAN, USP)|Valaciclovir (BAN, INN)|Valacyclovir (MI)|";"J05AB11";"J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1349"
"CHEMBL485";"CODEINE";"Small molecule";"4";"1952";"";"COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314";"Opioid receptors; mu/kappa/delta agonist";"";"";"CHEMBL2095181";"Opioid receptors; mu/kappa/delta";"AGONIST";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: PubMed RefID: 15611852 URL: http://europepmc.org/abstract/MED/15611852|Type: PubMed RefID: 17620111 URL: http://europepmc.org/abstract/MED/17620111|Type: Wikipedia RefID: Codeine URL: http://en.wikipedia.org/wiki/Codeine|Type: Wikipedia RefID: Opioid_receptor URL: http://en.wikipedia.org/wiki/Opioid_receptor";"Codeine (BAN, MI, USP, BAN)|Codeine sulfate (FDA, MI, USP)|Codeine sulfate cii (USP)|Codeine Phosphate (BAN, FDA, JAN, MI, USP)|Codeine phosphate cii (USP)|Codeine phosphate hydrate (JAN)|Codeine Polistirex (FDA, USAN)|";"R05DA04 | N02AA59 | N02AA79";"R05DA - Opium alkaloids and derivatives | N02AA - Natural opium alkaloids | N02AA - Natural opium alkaloids";"R05D - COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS | N02A - OPIOIDS | N02A - OPIOIDS";"R05 - COUGH AND COLD PREPARATIONS | N02 - ANALGESICS | N02 - ANALGESICS";"R - RESPIRATORY SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM";"CHEMBL485"
"CHEMBL190461";"CANNABIDIOL";"Small molecule";"4";"2018";"'-nab-'";"C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O";"Cannabinoid CB1 receptor negative allosteric modulator";"";"";"CHEMBL218";"Cannabinoid CB1 receptor";"NEGATIVE ALLOSTERIC MODULATOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 26218440 URL: http://europepmc.org/abstract/MED/26218440";"Cannabidiol (FDA, INN, MI, USAN)|";"N03AX24";"N03AX - Other antiepileptics";"N03A - ANTIEPILEPTICS";"N03 - ANTIEPILEPTICS";"N - NERVOUS SYSTEM";"CHEMBL190461"
"CHEMBL584";"NELFINAVIR";"Small molecule";"4";"1997";"'-vir'";"Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C";"Human immunodeficiency virus type 1 protease inhibitor";"";"";"CHEMBL243";"Human immunodeficiency virus type 1 protease";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=e72c2bc6-9462-4a2e-8e1d-b97592376cbd URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e72c2bc6-9462-4a2e-8e1d-b97592376cbd";"Nelfinavir mesilate (JAN)|Nelfinavir mesylate (FDA, USAN, USP)|Nelfinavir methanesulfonate (MI)|Nelfinavir (BAN, INN, MI)|";"J05AE04";"J05AE - Protease inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL584"
"CHEMBL2107834";"RIOCIGUAT";"Small molecule";"4";"2013";"'-ciguat'";"COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N";"Soluble guanylate cyclase positive allosteric modulator";"Riociguat has a dual mode of action. It sensitizes sGC to endogenous NO by stabilizing the NO-sGC binding and it also directly stimulates sGC via a different binding site, independently of NO. Recent studies have suggested that sCG stimulators bind to an allosteric nucleotide-binding site in the catalytic domains of sCG. The exact molecular mechanism of sCG stimulation remains a matter of debate.";"";"CHEMBL2111348";"Soluble guanylate cyclase";"POSITIVE ALLOSTERIC MODULATOR";"PROTEIN COMPLEX GROUP";"Homo sapiens";"";"";"Type: DailyMed RefID: 7b57509a-3d5d-41d4-8fed-1471e26372a3 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b57509a-3d5d-41d4-8fed-1471e26372a3|Type: PubMed RefID: 16955067 URL: http://europepmc.org/abstract/MED/16955067|Type: PubMed RefID: 19263460 URL: http://europepmc.org/abstract/MED/19263460";"Riociguat (FDA, INN, JAN, MI, USAN)|";"C02KX05";"C02KX - Antihypertensives for pulmonary arterial hypertension";"C02K - OTHER ANTIHYPERTENSIVES";"C02 - ANTIHYPERTENSIVES";"C - CARDIOVASCULAR SYSTEM";"CHEMBL2107834"
"CHEMBL1743029";"IBALIZUMAB";"Antibody";"4";"2018";"'-mab'";"";"T-cell surface antigen CD4 inhibitor";"Binds CD4, the primary receptor for human immunodeficiency virus type 1 (HIV-1), and inhibits the viral entry process.";"";"CHEMBL2754";"T-cell surface antigen CD4";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 19015347 URL: http://europepmc.org/abstract/MED/19015347|Type: PubMed RefID: 21134642 URL: http://europepmc.org/abstract/MED/21134642";"Ibalizumab (INN, USAN)|Ibalizumab-uiyk (FDA)|";"J05AX23";"J05AX - Other antivirals";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1743029"
"CHEMBL820";"BUSULFAN";"Small molecule";"4";"1954";"'-sulfan'";"CS(=O)(=O)OCCCCOS(C)(=O)=O";"DNA inhibitor";"";"";"CHEMBL2311221";"DNA";"INHIBITOR";"NUCLEIC-ACID";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=03dc50f9-c7bd-4c0c-8bbb-c1216ec90c95 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03dc50f9-c7bd-4c0c-8bbb-c1216ec90c95";"Busulfan (BAN, FDA, INN, JAN, MI, USP)|";"L01AB01";"L01AB - Alkyl sulfonates";"L01A - ALKYLATING AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL820"
"CHEMBL2109047";"INTERFERON ALFA-N3";"Protein";"4";"1989";"";"";"Interferon alpha/beta receptor agonist";"";"";"CHEMBL2364170";"Interferon alpha/beta receptor";"AGONIST";"PROTEIN COMPLEX";"Homo sapiens";"";"Alpha subunit is binding site";"Type: PubMed RefID: 10049744 URL: http://europepmc.org/abstract/MED/10049744";"Interferon Alfa-N3 (FDA, USAN)|";"";"";"";"";"";"CHEMBL2109047"
"CHEMBL2108508";"INTERFERON ALFA-2A";"Protein";"4";"1986";"";"";"Interferon alpha/beta receptor agonist";"";"";"CHEMBL2364170";"Interferon alpha/beta receptor";"AGONIST";"PROTEIN COMPLEX";"Homo sapiens";"";"Alpha subunit is binding site";"Type: PubMed RefID: 10049744 URL: http://europepmc.org/abstract/MED/10049744";"Interferon Alfa-2A (BAN, FDA, INN, USAN)|Interferon Alfa-2A (Genetical Recombination) (JAN)|";"L03AB04";"L03AB - Interferons";"L03A - IMMUNOSTIMULANTS";"L03 - IMMUNOSTIMULANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL2108508"
"CHEMBL76";"CHLOROQUINE";"Small molecule";"4";"1949";"";"CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12";"Ferriprotoporphyrin IX inhibitor";"prevents crystallisation";"";"CHEMBL613897";"Ferriprotoporphyrin IX";"INHIBITOR";"SMALL MOLECULE";"Plasmodium falciparum";"";"";"Type: PubMed RefID: 14967191 URL: http://europepmc.org/abstract/MED/14967191";"Chloroquine sulfate (MI, USP)|Chloroquine Diphosphate (MI)|Chloroquine Phosphate (BAN, FDA, USP)|Chloroquine (BAN, INN, MI, USP)|Chloroquine HCl (FDA, USP)|";"P01BA01";"P01BA - Aminoquinolines";"P01B - ANTIMALARIALS";"P01 - ANTIPROTOZOALS";"P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS";"CHEMBL76"
"CHEMBL1144";"PRAVASTATIN";"Small molecule";"4";"1991";"'-stat-'";"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21";"HMG-CoA reductase inhibitor";"";"";"CHEMBL402";"HMG-CoA reductase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=897ad8b7-921d-eb02-a61c-3419e662a2da URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=897ad8b7-921d-eb02-a61c-3419e662a2da";"Pravastatin (BAN, INN)|Pravastatin sodium (FDA, JAN, USAN)|Pravastatin Sodium (MI, USP)|";"C10AA03";"C10AA - HMG CoA reductase inhibitors";"C10A - LIPID MODIFYING AGENTS, PLAIN";"C10 - LIPID MODIFYING AGENTS";"C - CARDIOVASCULAR SYSTEM";"CHEMBL1144"
"CHEMBL88";"CYCLOPHOSPHAMIDE";"Small molecule";"4";"1959";"";"O=P1(N(CCCl)CCCl)NCCCO1";"DNA inhibitor";"";"";"CHEMBL2311221";"DNA";"INHIBITOR";"NUCLEIC-ACID";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=367b47d7-c4de-4b39-bd3a-69c29d80396f URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=367b47d7-c4de-4b39-bd3a-69c29d80396f";"Cyclophosphamide (BAN, FDA, INN, JAN, MI, USP, BAN, JAN, USP)|Cyclophosphamide anhydrous (MI)|Cyclophosphamide hydrate (JAN)|";"";"";"";"";"";"CHEMBL88"
"CHEMBL848";"LENALIDOMIDE";"Small molecule";"4";"2005";"'-domide; -nal-'";"Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O";"CRL4(CRBN) E3 ubiquitin ligase inhibitor";"";"";"CHEMBL3833061";"CRL4(CRBN) E3 ubiquitin ligase";"INHIBITOR";"PROTEIN COMPLEX";"Homo sapiens";"";"Cereblon";"Type: PubMed RefID: 22552008 URL: http://europepmc.org/abstract/MED/22552008|Type: PubMed RefID: 25043012 URL: http://europepmc.org/abstract/MED/25043012";"Lenalidomide (BAN, FDA, INN, MI, USAN)|";"L04AX04";"L04AX - Other immunosuppressants";"L04A - IMMUNOSUPPRESSANTS";"L04 - IMMUNOSUPPRESSANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL848"
"CHEMBL1483";"ALBENDAZOLE";"Small molecule";"4";"1996";"'-bendazole'";"CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1";"Tubulin inhibitor";"";"";"CHEMBL2364705";"Tubulin";"INHIBITOR";"PROTEIN COMPLEX GROUP";"Nematoda";"Beta tubulin";"Binds to beta tubulin";"Type: DailyMed RefID: setid=e8941166-b77d-45aa-a6e8-04f1c0afd845 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8941166-b77d-45aa-a6e8-04f1c0afd845|Type: ISBN RefID: 9780702034718 PP. 669 URL: http://www.isbnsearch.org/isbn/9780702034718|Type: PubMed RefID: 13678839 URL: http://europepmc.org/abstract/MED/13678839";"Albendazole (BAN, FDA, INN, JAN, MI, USAN, USP)|";"P02CA03";"P02CA - Benzimidazole derivatives";"P02C - ANTINEMATODAL AGENTS";"P02 - ANTHELMINTICS";"P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS";"CHEMBL1483"
"CHEMBL467";"HYDROXYUREA";"Small molecule";"4";"1967";"";"NC(=O)NO";"Ribonucleoside-diphosphate reductase RR1 inhibitor";"";"";"CHEMBL2095215";"Ribonucleoside-diphosphate reductase RR1";"INHIBITOR";"PROTEIN COMPLEX GROUP";"Homo sapiens";"Ribonucleoside-diphosphate reductase M2 subunit";"M2 subunit is binding site";"Type: DailyMed RefID: setid=740e054b-faac-7c27-f06d-a56efb699355 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=740e054b-faac-7c27-f06d-a56efb699355|Type: PubMed RefID: 23115527 URL: http://europepmc.org/abstract/MED/23115527";"Hydroxycarbamide (INN, JAN)|Hydroxyurea (BAN, FDA, MI, USAN, USP)|";"L01XX05";"L01XX - Other antineoplastic agents";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL467"
"CHEMBL52440";"DEXTROMETHORPHAN";"Small molecule";"4";"1982";"'-orphan'";"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3";"Glutamate [NMDA] receptor subunit epsilon 1 antagonist";"";"";"CHEMBL1972";"Glutamate [NMDA] receptor subunit epsilon 1";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 2897648 URL: http://europepmc.org/abstract/MED/2897648|Type: Wikipedia RefID: Dextromethorphan URL: http://en.wikipedia.org/wiki/Dextromethorphan|Type: Wikipedia RefID: Nmda_receptor_antagonist URL: http://en.wikipedia.org/wiki/Nmda_receptor_antagonist";"Dextromethorphan Polistirex (FDA, USAN)|Dextromethorphan Hydrobromide (BAN, FDA, JAN, USP)|Deudextromethorphan (USAN)|Dextromethorphan (BAN, INN, USP)|Deudextromethorphan hydrobromide (USAN)|";"N07XX59 | R05DA09";"N07XX - Other nervous system drugs | R05DA - Opium alkaloids and derivatives";"N07X - OTHER NERVOUS SYSTEM DRUGS | R05D - COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS";"N07 - OTHER NERVOUS SYSTEM DRUGS | R05 - COUGH AND COLD PREPARATIONS";"N - NERVOUS SYSTEM | R - RESPIRATORY SYSTEM";"CHEMBL52440"
"CHEMBL1017";"TELMISARTAN";"Small molecule";"4";"1998";"'-sartan'";"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"Type-1 angiotensin II receptor antagonist";"";"";"CHEMBL227";"Type-1 angiotensin II receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=cfb9309f-e0df-4a55-9542-0e869fce05fb#section-14 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfb9309f-e0df-4a55-9542-0e869fce05fb#section-14|Type: PubMed RefID: 16938288 URL: http://europepmc.org/abstract/MED/16938288|Type: PubMed RefID: 18580862 URL: http://europepmc.org/abstract/MED/18580862|Type: Wikipedia RefID: Telmisartan URL: http://en.wikipedia.org/wiki/Telmisartan";"Telmisartan (BAN, FDA, INN, JAN, MI, USAN, USP)|";"C09CA07";"C09CA - Angiotensin II receptor blockers (ARBs), plain";"C09C - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN";"C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM";"C - CARDIOVASCULAR SYSTEM";"CHEMBL1017"
"CHEMBL444633";"RIFABUTIN";"Small molecule";"4";"1992";"'rifa-'";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O";"Bacterial DNA-directed RNA polymerase inhibitor";"";"";"CHEMBL2364672";"Bacterial DNA-directed RNA polymerase";"INHIBITOR";"PROTEIN COMPLEX";"Bacteria";"RNA polymerase beta/beta prime subunit";"Beta subunit is binding site";"Type: PubMed RefID: 7849340 URL: http://europepmc.org/abstract/MED/7849340";"Rifabutin (BAN, FDA, INN, JAN, MI, USAN, USP)|";"J04AB04";"J04AB - Antibiotics";"J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS";"J04 - ANTIMYCOBACTERIALS";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL444633"
"CHEMBL2103792";"AGATOLIMOD";"Oligonucleotide";"3";"";"'-imod'";"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3CO)O2)c(=O)[nH]c1=O";"Toll-like receptor 9 agonist";"Targets TLR9, thereby activating dendritic and B cells and stimulating cytotoxic T cell and antibody responses against tumor cells bearing tumor antigens";"";"CHEMBL5804";"Toll-like receptor 9";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: Other RefID: https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=38660 URL: https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=38660|Type: PubMed RefID: 18596994 URL: http://europepmc.org/abstract/MED/18596994";"Agatolimod (INN, MI, USAN)|Agatolimod Sodium (USAN)|Agatolimod tricosasodium salt (MI)|";"";"";"";"";"";"CHEMBL2103792"
"CHEMBL389621";"HYDROCORTISONE";"Small molecule";"4";"1952";"'-cort-'";"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO";"Glucocorticoid receptor agonist";"";"";"CHEMBL2034";"Glucocorticoid receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 16895953 URL: http://europepmc.org/abstract/MED/16895953|Type: PubMed RefID: 16980198 URL: http://europepmc.org/abstract/MED/16980198|Type: PubMed RefID: 17038445 URL: http://europepmc.org/abstract/MED/17038445|Type: PubMed RefID: 17086345 URL: http://europepmc.org/abstract/MED/17086345";"Hydrocortisone (BAN, FDA, INN, JAN, MI, USP)|";"A07EA02 | H02AB09 | S02BA01 | S01CB03 | D07XA01 | C05AA01 | A01AC03 | D07AA02 | R01AD60 | S01BA02";"A07EA - Corticosteroids acting locally | H02AB - Glucocorticoids | S02BA - Corticosteroids | S01CB - Corticosteroids/antiinfectives/mydriatics in combination | D07XA - Corticosteroids, weak, other combinations | C05AA - Corticosteroids | A01AC - Corticosteroids for local oral treatment | D07AA - Corticosteroids, weak (group I) | R01AD - Corticosteroids | S01BA - Corticosteroids, plain";"A07E - INTESTINAL ANTIINFLAMMATORY AGENTS | H02A - CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | S02B - CORTICOSTEROIDS | S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION | D07X - CORTICOSTEROIDS, OTHER COMBINATIONS | C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE | A01A - STOMATOLOGICAL PREPARATIONS | D07A - CORTICOSTEROIDS, PLAIN | R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE | S01B - ANTIINFLAMMATORY AGENTS";"A07 - ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS | H02 - CORTICOSTEROIDS FOR SYSTEMIC USE | S02 - OTOLOGICALS | S01 - OPHTHALMOLOGICALS | D07 - CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS | C05 - VASOPROTECTIVES | A01 - STOMATOLOGICAL PREPARATIONS | D07 - CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS | R01 - NASAL PREPARATIONS | S01 - OPHTHALMOLOGICALS";"A - ALIMENTARY TRACT AND METABOLISM | H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | S - SENSORY ORGANS | S - SENSORY ORGANS | D - DERMATOLOGICALS | C - CARDIOVASCULAR SYSTEM | A - ALIMENTARY TRACT AND METABOLISM | D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM | S - SENSORY ORGANS";"CHEMBL389621"
"CHEMBL3137343";"PEMBROLIZUMAB";"Antibody";"4";"2014";"'-mab'";"";"Programmed cell death protein 1 inhibitor";"";"";"CHEMBL3307223";"Programmed cell death protein 1";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2014/125514lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125514lbl.pdf";"Pembrolizumab (FDA, INN, JAN, MI, USAN)|";"L01XC18";"L01XC - Monoclonal antibodies";"L01X - OTHER ANTINEOPLASTIC AGENTS";"L01 - ANTINEOPLASTIC AGENTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL3137343"
"CHEMBL1276308";"MIFEPRISTONE";"Small molecule";"4";"2000";"'-pristone'";"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C";"Glucocorticoid receptor antagonist";"";"Selective";"CHEMBL2034";"Glucocorticoid receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9|Type: PubMed RefID: 22466348 URL: http://europepmc.org/abstract/MED/22466348";"Mifepristone (BAN, FDA, INN, JAN, MI, USAN, USP)|";"G03XB51 | G03XB01";"G03XB - Progesterone receptor modulators | G03XB - Progesterone receptor modulators";"G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL1276308"
"CHEMBL1201134";"LUBIPROSTONE";"Small molecule";"4";"2006";"'-prost-'";"CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1";"Chloride channel protein 2 opener";"";"";"CHEMBL1628478";"Chloride channel protein 2";"OPENER";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=417aa15d-ac74-4fa8-a312-6e51e82ba70c#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=417aa15d-ac74-4fa8-a312-6e51e82ba70c#nlm34090-1";"Lubiprostone (FDA, INN, JAN, MI, USAN)|";"A06AX03";"A06AX - Other drugs for constipation";"A06A - DRUGS FOR CONSTIPATION";"A06 - DRUGS FOR CONSTIPATION";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1201134"
"CHEMBL1201567";"FILGRASTIM";"Protein";"4";"1991";"'-stim'";"";"Granulocyte colony stimulating factor receptor agonist";"";"";"CHEMBL1996";"Granulocyte colony stimulating factor receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=fdfe5d72-6b80-435a-afa4-c5d74dd852ce URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fdfe5d72-6b80-435a-afa4-c5d74dd852ce|Type: PubMed RefID: 7504384 URL: http://europepmc.org/abstract/MED/7504384|Type: PubMed RefID: 9679526 URL: http://europepmc.org/abstract/MED/9679526";"Filgrastim (BAN, FDA, INN, JAN, USAN)|Filgrastim-sndz (FDA)|Tbo-Filgrastim (FDA)|";"L03AA02";"L03AA - Colony stimulating factors";"L03A - IMMUNOSTIMULANTS";"L03 - IMMUNOSTIMULANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1201567"
"CHEMBL1688243";"INCB-9471";"Small molecule";"2";"";"";"CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C";"C-C chemokine receptor type 5 antagonist";"HIV-1 entry inhibitor, noncompetitive CCR5 allosteric antagonist. Indication: HIV infections";"";"CHEMBL274";"C-C chemokine receptor type 5";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 21459966 URL: http://europepmc.org/abstract/MED/21459966|Type: PubMed RefID: 24900235 URL: http://europepmc.org/abstract/MED/24900235";"INCB-9471";"";"";"";"";"";"CHEMBL1688243"
"CHEMBL2095208";"COBICISTAT";"Small molecule";"4";"2012";"'-stat'";"CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1";"Cytochrome P450 3A inhibitor";"";"";"CHEMBL2364675";"Cytochrome P450 3A";"INHIBITOR";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=74ae2a93-b267-444c-8f0f-a2a6522260ee URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74ae2a93-b267-444c-8f0f-a2a6522260ee|Type: DOI RefID: 10.1021/ml1000257 URL: http://pubs.acs.org/doi/abs/10.1021/ml1000257";"Cobicistat (FDA, INN, JAN, MI, USAN)|";"V03AX03";"V03AX - Other therapeutic products";"V03A - ALL OTHER THERAPEUTIC PRODUCTS";"V03 - ALL OTHER THERAPEUTIC PRODUCTS";"V - VARIOUS";"CHEMBL2095208"
"CHEMBL1535";"HYDROXYCHLOROQUINE";"Small molecule";"4";"1955";"";"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12";"Toll-like receptor 9 antagonist";"";"";"CHEMBL5804";"Toll-like receptor 9";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2007/009768s041lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/009768s041lbl.pdf|Type: PubMed RefID: 17970883 URL: http://europepmc.org/abstract/MED/17970883|Type: PubMed RefID: 18220957 URL: http://europepmc.org/abstract/MED/18220957";"Hydroxychloroquine sulfate (FDA, USP)|Hydroxychloroquine Sulfate (MI)|Hydroxychloroquine (BAN, INN, MI)|";"P01BA02";"P01BA - Aminoquinolines";"P01B - ANTIMALARIALS";"P01 - ANTIPROTOZOALS";"P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS";"CHEMBL1535"
"CHEMBL493982";"VORAPAXAR";"Small molecule";"4";"2014";"'-paxar'";"CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1";"Proteinase-activated receptor 1 antagonist";"";"";"CHEMBL3974";"Proteinase-activated receptor 1";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: FDA RefID: label/2014/204886s000lbl.pdf URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204886s000lbl.pdf";"Vorapaxar Sulfate (FDA, JAN, MI, USAN)|Vorapaxar (INN, MI, USAN)|";"B01AC26";"B01AC - Platelet aggregation inhibitors excl. heparin";"B01A - ANTITHROMBOTIC AGENTS";"B01 - ANTITHROMBOTIC AGENTS";"B - BLOOD AND BLOOD FORMING ORGANS";"CHEMBL493982"
"CHEMBL511142";"BUPRENORPHINE";"Small molecule";"4";"1981";"";"CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5";"Mu opioid receptor agonist";"";"";"CHEMBL233";"Mu opioid receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=b086772e-d15a-4d13-b1a2-38bfbde1f18c#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b086772e-d15a-4d13-b1a2-38bfbde1f18c#nlm34090-1";"Buprenorphine HCl (FDA, JAN, MI, USAN, USP)|Buprenorphine hydrochloride ciii (USP)|Buprenorphine (BAN, FDA, INN, JAN, MI)|";"N07BC01 | N02AE01 | N07BC51";"N07BC - Drugs used in opioid dependence | N02AE - Oripavine derivatives | N07BC - Drugs used in opioid dependence";"N07B - DRUGS USED IN ADDICTIVE DISORDERS | N02A - OPIOIDS | N07B - DRUGS USED IN ADDICTIVE DISORDERS";"N07 - OTHER NERVOUS SYSTEM DRUGS | N02 - ANALGESICS | N07 - OTHER NERVOUS SYSTEM DRUGS";"N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM";"CHEMBL511142"
"CHEMBL1237026";"TESAMORELIN";"Protein";"4";"2010";"'-relin'";"";"Growth hormone-releasing hormone receptor agonist";"";"";"CHEMBL2032";"Growth hormone-releasing hormone receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=3de31cec-31dc-4ac4-9717-367a687d22f2 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3de31cec-31dc-4ac4-9717-367a687d22f2";"Tesamorelin Acetate (FDA, USAN)|Tesamorelin (INN, MI, USAN)|";"H01AC06";"H01AC - Somatropin and somatropin agonists";"H01A - ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES";"H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES";"H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS";"CHEMBL1237026"
"CHEMBL126";"LINEZOLID";"Small molecule";"4";"2000";"'-zolid'";"CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1";"Bacterial 70S ribosome inhibitor";"Indicated for Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae, Enterococcus faecium";"";"CHEMBL2363135";"Bacterial 70S ribosome";"INHIBITOR";"PROTEIN NUCLEIC-ACID COMPLEX";"Bacteria";"23S ribosomal RNA";"23S RRNA";"Type: DailyMed RefID: setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd|Type: PubMed RefID: 15992144 URL: http://europepmc.org/abstract/MED/15992144";"Linezolid (BAN, FDA, INN, JAN, MI, USAN, USP)|";"J01XX08";"J01XX - Other antibacterials";"J01X - OTHER ANTIBACTERIALS";"J01 - ANTIBACTERIALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL126"
"CHEMBL666";"FOSCARNET";"Small molecule";"4";"1991";"'fos-'";"O=C(O)P(=O)(O)O";"Human herpesvirus 1 DNA polymerase inhibitor";"";"";"CHEMBL1872";"Human herpesvirus 1 DNA polymerase";"INHIBITOR";"SINGLE PROTEIN";"Herpes simplex virus (type 1 / strain 17)";"";"";"Type: DailyMed RefID: setid=eec8727b-c98c-41a4-90b8-d49a8e01e63c URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eec8727b-c98c-41a4-90b8-d49a8e01e63c";"Foscarnet Sodium (BAN, FDA, INN, MI, USAN, USP)|Foscarnet sodium hexahydrate (MI)|Foscarnet sodium hydrate (JAN)|";"J05AD01";"J05AD - Phosphonic acid derivatives";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL666"
"CHEMBL2109443";"F105";"Antibody";"1";"";"";"";"Envelope polyprotein GP160 inhibitor";"";"";"CHEMBL3520";"Envelope polyprotein GP160";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1)";"";"";"Type: PubMed RefID: 9591708 URL: http://europepmc.org/abstract/MED/9591708";"F105";"";"";"";"";"";"CHEMBL2109443"
"CHEMBL1237022";"TOCILIZUMAB";"Antibody";"4";"2005";"'-mab'";"";"Interleukin-6 receptor alpha subunit inhibitor";"Complex with beta subunit in membrane bound form, but binds to soluble (alpha only) form too";"";"CHEMBL2364155";"Interleukin-6 receptor alpha subunit";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"Alpha subunit is binding site";"Type: DailyMed RefID: setid=2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13";"Tocilizumab (FDA, INN, MI, USAN)|";"L04AC07";"L04AC - Interleukin inhibitors";"L04A - IMMUNOSUPPRESSANTS";"L04 - IMMUNOSUPPRESSANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1237022"
"CHEMBL1201482";"PROTEASE (PANCRELIPASE)";"Enzyme";"4";"1996";"'-ase'";"";"Polypeptides hydrolytic enzyme";"";"";"CHEMBL2364181";"Polypeptides";"HYDROLYTIC ENZYME";"MACROMOLECULE";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=073201aa-556d-4a70-918e-84e9616fd88d#nlm34090-1";"Pancrelipase (FDA)|";"A09AA02";"A09AA - Enzyme preparations";"A09A - DIGESTIVES, INCL. ENZYMES";"A09 - DIGESTIVES, INCL. ENZYMES";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1201482"
"CHEMBL2364608";"DORAVIRINE";"Small molecule";"4";"2018";"'-vir-'";"Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)n[nH]c1=O";"Reverse transcriptase negative allosteric modulator";"Inhibits reverse transcriptase and viral replication.";"Does not inhibit human cellular DNA polymerases alpha and beta or mitochondrial DNA polymerase gamma. Active against a range of HIV-1 isolates from different groups. ";"CHEMBL2366516";"Reverse transcriptase";"NEGATIVE ALLOSTERIC MODULATOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"NNRTI binding site";"Type: FDA RefID: label/2018/210806s000lbl.pdf URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210806s000lbl.pdf|Type: PubMed RefID: 27124362 URL: http://europepmc.org/abstract/MED/27124362";"Doravirine (FDA, INN, USAN)|";"J05AG06";"J05AG - Non-nucleoside reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL2364608"
"CHEMBL1276308";"MIFEPRISTONE";"Small molecule";"4";"2000";"'-pristone'";"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C";"Progesterone receptor antagonist";"";"Selective";"CHEMBL208";"Progesterone receptor";"ANTAGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9";"Mifepristone (BAN, FDA, INN, JAN, MI, USAN, USP)|";"G03XB51 | G03XB01";"G03XB - Progesterone receptor modulators | G03XB - Progesterone receptor modulators";"G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM";"G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL1276308"
"CHEMBL141";"LAMIVUDINE";"Small molecule";"4";"1995";"'-vudine'";"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1";"DNA inhibitor";"When monophosporylated is incorporates into the DNA, when triphosporylated inhibits the enzymes";"";"CHEMBL2363048";"DNA";"INHIBITOR";"NUCLEIC-ACID";"Hepatitis B virus";"";"";"Type: DailyMed RefID: setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc62b38c-4cc9-4e64-8852-1a0be6d36d8e";"Lamivudine (BAN, FDA, INN, JAN, MI, USAN, USP)|";"J05AF05";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL141"
"CHEMBL106";"FLUCONAZOLE";"Small molecule";"4";"1990";"'-conazole'";"OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F";"Cytochrome P450 51 inhibitor";"";"";"CHEMBL1780";"Cytochrome P450 51";"INHIBITOR";"SINGLE PROTEIN";"Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)";"";"";"Type: DailyMed RefID: setid=f694c617-3383-416c-91b6-b94fda371204 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f694c617-3383-416c-91b6-b94fda371204";"Fluconazole (BAN, FDA, INN, JAN, MI, USAN, USP)|";"D01AC15 | J02AC01";"D01AC - Imidazole and triazole derivatives | J02AC - Triazole derivatives";"D01A - ANTIFUNGALS FOR TOPICAL USE | J02A - ANTIMYCOTICS FOR SYSTEMIC USE";"D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE | J02 - ANTIMYCOTICS FOR SYSTEMIC USE";"D - DERMATOLOGICALS | J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL106"
"CHEMBL174";"AMPICILLIN";"Small molecule";"4";"1965";"'-cillin'";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"Bacterial penicillin-binding protein inhibitor";"";"";"CHEMBL2354204";"Bacterial penicillin-binding protein";"INHIBITOR";"PROTEIN FAMILY";"Bacteria";"";"";"Type: PubMed RefID: 7447421 URL: http://europepmc.org/abstract/MED/7447421|Type: Wikipedia RefID: Penicillin_binding_proteins#Function URL: http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function";"Ampicillin (BAN, INN, JAN, MI, USAN, USP)|Ampicillin/Ampicillin Trihydrate (FDA)|Anhydrous ampicillin (JAN)|Ampicillin Sodium (FDA, JAN, USAN, USP)|Ampicillin sodium salt (MI)|";"S01AA19 | J01CA51 | J01CA01";"S01AA - Antibiotics | J01CA - Penicillins with extended spectrum | J01CA - Penicillins with extended spectrum";"S01A - ANTIINFECTIVES | J01C - BETA-LACTAM ANTIBACTERIALS, PENICILLINS | J01C - BETA-LACTAM ANTIBACTERIALS, PENICILLINS";"S01 - OPHTHALMOLOGICALS | J01 - ANTIBACTERIALS FOR SYSTEMIC USE | J01 - ANTIBACTERIALS FOR SYSTEMIC USE";"S - SENSORY ORGANS | J - ANTIINFECTIVES FOR SYSTEMIC USE | J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL174"
"CHEMBL112";"ACETAMINOPHEN";"Small molecule";"4";"1968";"";"CC(=O)Nc1ccc(O)cc1";"Vanilloid receptor opener";"Active metabolite, AM404, activates vanilloid receptor (TRPV1)";"";"CHEMBL4794";"Vanilloid receptor";"OPENER";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: PubMed RefID: 15987694 URL: http://europepmc.org/abstract/MED/15987694|Type: PubMed RefID: 20862299 URL: http://europepmc.org/abstract/MED/20862299|Type: Wikipedia RefID: Acetaminophen#Mechanism_of_action URL: http://en.wikipedia.org/wiki/Acetaminophen#Mechanism_of_action";"Acetaminophen (FDA, JAN, MI, USP)|Paracetamol (BAN, DCF, INN)|";"N02BE71 | N02BE51 | N02BE01";"N02BE - Anilides | N02BE - Anilides | N02BE - Anilides";"N02B - OTHER ANALGESICS AND ANTIPYRETICS | N02B - OTHER ANALGESICS AND ANTIPYRETICS | N02B - OTHER ANALGESICS AND ANTIPYRETICS";"N02 - ANALGESICS | N02 - ANALGESICS | N02 - ANALGESICS";"N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM";"CHEMBL112"
"CHEMBL86";"METOCLOPRAMIDE";"Small molecule";"4";"1979";"";"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC";"Serotonin 4 (5-HT4) receptor agonist";"";"";"CHEMBL1875";"Serotonin 4 (5-HT4) receptor";"AGONIST";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: ISBN RefID: 0443-059748 PP. 167 URL: http://www.isbnsearch.org/isbn/0443059748|Type: Wikipedia RefID: Metoclopramide URL: http://en.wikipedia.org/wiki/Metoclopramide";"Metoclopramide (JAN, BAN, INN, JAN, MI)|Metoclopramide HCl (FDA, JAN, USAN, USP)|";"A03FA01";"A03FA - Propulsives";"A03F - PROPULSIVES";"A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL86"
"CHEMBL1643";"RIBAVIRIN";"Small molecule";"4";"1985";"'-vir-'";"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1";"RNA inhibitor";"";"";"CHEMBL2363073";"RNA";"INHIBITOR";"NUCLEIC-ACID";"Hepatitis C virus";"";"";"Type: PubMed RefID: 16107837 URL: http://europepmc.org/abstract/MED/16107837|Type: Wikipedia RefID: Ribavirin#Mechanisms_of_action URL: http://en.wikipedia.org/wiki/Ribavirin#Mechanisms_of_action";"Ribavirin (FDA, INN, JAN, MI, USAN, USP)|Tribavirin (BAN)|";"J05AP01";"J05AP - Antivirals for treatment of HCV infections";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1643"
"CHEMBL529";"AZITHROMYCIN";"Small molecule";"4";"1991";"'-mycin'";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"Bacterial 70S ribosome inhibitor";"";"";"CHEMBL2363135";"Bacterial 70S ribosome";"INHIBITOR";"PROTEIN NUCLEIC-ACID COMPLEX";"Bacteria";"23S ribosomal RNA";"23S RRNA";"Type: PubMed RefID: 12623020 URL: http://europepmc.org/abstract/MED/12623020|Type: PubMed RefID: 15851032 URL: http://europepmc.org/abstract/MED/15851032|Type: PubMed RefID: 19071138 URL: http://europepmc.org/abstract/MED/19071138";"Azithromycin (BAN, FDA, INN, MI, USAN, USP)|Azithromycin Dihydrate (FDA, MI)|Azithromycin hydrate (JAN)|";"J01FA10 | S01AA26";"J01FA - Macrolides | S01AA - Antibiotics";"J01F - MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS | S01A - ANTIINFECTIVES";"J01 - ANTIBACTERIALS FOR SYSTEMIC USE | S01 - OPHTHALMOLOGICALS";"J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS";"CHEMBL529"
"CHEMBL70663";"DAPIVIRINE";"Small molecule";"3";"";"'-vir-'";"Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1";"Reverse transcriptase inhibitor";"";"";"CHEMBL2366516";"Reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: PubMed RefID: 19029331 URL: http://europepmc.org/abstract/MED/19029331";"Dapivirine (INN, USAN)|";"G01AX17";"G01AX - Other antiinfectives and antiseptics";"G01A - ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS";"G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS";"G - GENITO URINARY SYSTEM AND SEX HORMONES";"CHEMBL70663"
"CHEMBL1422";"SITAGLIPTIN";"Small molecule";"4";"2006";"'-gliptin'";"N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F";"Dipeptidyl peptidase IV inhibitor";"";"";"CHEMBL284";"Dipeptidyl peptidase IV";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=f85a48d0-0407-4c50-b0fa-7673a160bf01 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f85a48d0-0407-4c50-b0fa-7673a160bf01";"Sitagliptin monophosphate anhydrous (MI)|Sitagliptin monophosphate monohydrate (MI)|Sitagliptin Phosphate (FDA, USAN, USP)|Sitagliptin phosphate hydrate (JAN)|Sitagliptin (INN, MI)|";"A10BH01";"A10BH - Dipeptidyl peptidase 4 (DPP-4) inhibitors";"A10B - BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS";"A10 - DRUGS USED IN DIABETES";"A - ALIMENTARY TRACT AND METABOLISM";"CHEMBL1422"
"CHEMBL870";"ALENDRONIC ACID";"Small molecule";"4";"1995";"'-dronate'";"NCCCC(O)(P(=O)(O)O)P(=O)(O)O";"Farnesyl diphosphate synthase inhibitor";"Binds to the bone matrix (hydroxyapatite), and when the bone starts to be reabsorbed the compound is released and taken up by osteoclasts, inhibiting protein prenylation of the GTPases involved in the formation of the ruffled border";"";"CHEMBL1782";"Farnesyl diphosphate synthase";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: ISBN RefID: 9780702034718 PP. 437-438 URL: http://www.isbnsearch.org/isbn/9780702034718|Type: PubMed RefID: 11160603 URL: http://europepmc.org/abstract/MED/11160603|Type: PubMed RefID: 15028820 URL: http://europepmc.org/abstract/MED/15028820|Type: PubMed RefID: 16006204 URL: http://europepmc.org/abstract/MED/16006204|Type: PubMed RefID: 16835450 URL: http://europepmc.org/abstract/MED/16835450";"Alendronic Acid (BAN, INN, MI)|Alendronate Sodium (FDA, USAN, USP)|Alendronate sodium hydrate (JAN)|";"M05BA04";"M05BA - Bisphosphonates";"M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION";"M05 - DRUGS FOR TREATMENT OF BONE DISEASES";"M - MUSCULO-SKELETAL SYSTEM";"CHEMBL870"
"CHEMBL1380";"ABACAVIR";"Small molecule";"4";"1998";"'-vir'";"Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1";"Human immunodeficiency virus type 1 reverse transcriptase inhibitor";"";"";"CHEMBL247";"Human immunodeficiency virus type 1 reverse transcriptase";"INHIBITOR";"SINGLE PROTEIN";"Human immunodeficiency virus 1";"";"";"Type: DailyMed RefID: setid=80c1702a-973c-436a-90f8-69b29674dca0 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80c1702a-973c-436a-90f8-69b29674dca0";"Abacavir Succinate (USAN)|Abacavir Sulfate (FDA, JAN, MI, USAN, USP)|Abacavir (BAN, INN, MI)|";"J05AF06";"J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors";"J05A - DIRECT ACTING ANTIVIRALS";"J05 - ANTIVIRALS FOR SYSTEMIC USE";"J - ANTIINFECTIVES FOR SYSTEMIC USE";"CHEMBL1380"
"CHEMBL1201561";"PEGINTERFERON ALFA-2B";"Protein";"4";"2001";"'peg-'";"";"Interferon alpha/beta receptor agonist";"";"";"CHEMBL2364170";"Interferon alpha/beta receptor";"AGONIST";"PROTEIN COMPLEX";"Homo sapiens";"";"Alpha subunit is binding site";"Type: DailyMed RefID: setid=de61685e-2b8c-4e22-84bb-869e13600440 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de61685e-2b8c-4e22-84bb-869e13600440|Type: PubMed RefID: 17969444 URL: http://europepmc.org/abstract/MED/17969444";"Peginterferon alfa-2b (BAN, FDA, INN, JAN, MI, USAN)|";"L03AB10 | L03AB60";"L03AB - Interferons | L03AB - Interferons";"L03A - IMMUNOSTIMULANTS | L03A - IMMUNOSTIMULANTS";"L03 - IMMUNOSTIMULANTS | L03 - IMMUNOSTIMULANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1201561"
"CHEMBL413";"SIROLIMUS";"Small molecule";"4";"1999";"'-imus'";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"FK506-binding protein 1A inhibitor";"";"";"CHEMBL1902";"FK506-binding protein 1A";"INHIBITOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=3275b824-3f82-4151-2ab2-0036a9ba0acc#section-14 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3275b824-3f82-4151-2ab2-0036a9ba0acc#section-14";"Rapamycin (MI)|Sirolimus (BAN, FDA, INN, JAN, USAN)|";"L04AA10 | S01XA23";"L04AA - Selective immunosuppressants | S01XA - Other ophthalmologicals";"L04A - IMMUNOSUPPRESSANTS | S01X - OTHER OPHTHALMOLOGICALS";"L04 - IMMUNOSUPPRESSANTS | S01 - OPHTHALMOLOGICALS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | S - SENSORY ORGANS";"CHEMBL413"
"CHEMBL1201560";"PEGINTERFERON ALFA-2A";"Protein";"4";"2002";"'peg-'";"";"Interferon alpha/beta receptor agonist";"";"";"CHEMBL2364170";"Interferon alpha/beta receptor";"AGONIST";"PROTEIN COMPLEX";"Homo sapiens";"";"Alpha subunit is binding site";"Type: DailyMed RefID: setid=de61685e-2b8c-4e22-84bb-869e13600440 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de61685e-2b8c-4e22-84bb-869e13600440|Type: PubMed RefID: 17969444 URL: http://europepmc.org/abstract/MED/17969444";"Peginterferon alfa-2a (BAN, FDA, INN, JAN, MI, USAN)|";"L03AB11 | L03AB61";"L03AB - Interferons | L03AB - Interferons";"L03A - IMMUNOSTIMULANTS | L03A - IMMUNOSTIMULANTS";"L03 - IMMUNOSTIMULANTS | L03 - IMMUNOSTIMULANTS";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL1201560"
"CHEMBL932";"DIPYRIDAMOLE";"Small molecule";"4";"1961";"";"OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1";"3',5'-cyclic phosphodiesterase inhibitor";"";"";"CHEMBL2363066";"3',5'-cyclic phosphodiesterase";"INHIBITOR";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=ae7585ec-1280-40fe-b888-613b8a0e6ef6 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae7585ec-1280-40fe-b888-613b8a0e6ef6|Type: PubMed RefID: 15672122 URL: http://europepmc.org/abstract/MED/15672122|Type: Wikipedia RefID: Dipyridamole#Mechanism_and_effects URL: http://en.wikipedia.org/wiki/Dipyridamole#Mechanism_and_effects";"Dipyridamole (BAN, FDA, INN, JAN, MI, USAN, USP)|";"B01AC07";"B01AC - Platelet aggregation inhibitors excl. heparin";"B01A - ANTITHROMBOTIC AGENTS";"B01 - ANTITHROMBOTIC AGENTS";"B - BLOOD AND BLOOD FORMING ORGANS";"CHEMBL932"
"CHEMBL83";"TAMOXIFEN";"Small molecule";"4";"1977";"";"CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1";"Estrogen receptor alpha modulator";"Mixed agonist/antagonist";"";"CHEMBL206";"Estrogen receptor alpha";"MODULATOR";"SINGLE PROTEIN";"Homo sapiens";"";"";"Type: DailyMed RefID: setid=407a372d-4448-4d53-afd4-eb0e74bbc336 URL: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=407a372d-4448-4d53-afd4-eb0e74bbc336|Type: PubMed RefID: 18819158 URL: http://europepmc.org/abstract/MED/18819158|Type: Wikipedia RefID: Tamoxifen URL: http://en.wikipedia.org/wiki/Tamoxifen";"Tamoxifen (BAN, INN, MI)|Tamoxifen citrate (FDA, JAN, MI, USAN, USP)|";"L02BA01";"L02BA - Anti-estrogens";"L02B - HORMONE ANTAGONISTS AND RELATED AGENTS";"L02 - ENDOCRINE THERAPY";"L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"CHEMBL83"
"CHEMBL521";"IBUPROFEN";"Small molecule";"4";"1974";"'-profen'";"CC(C)Cc1ccc(C(C)C(=O)O)cc1";"Cyclooxygenase inhibitor";"";"";"CHEMBL2094253";"Cyclooxygenase";"INHIBITOR";"PROTEIN FAMILY";"Homo sapiens";"";"";"Type: ISBN RefID: 0443-059748 PP. 229 URL: http://www.isbnsearch.org/isbn/0443059748|Type: Wikipedia RefID: Ibuprofen URL: http://en.wikipedia.org/wiki/Ibuprofen";"Ibuprofen (BAN, FDA, INN, JAN, MI, USAN, USP)|Ibuprofen Sodium (FDA, USAN)|Ibuprofen Lysine (FDA, USAN)|";"M02AA13 | M01AE51 | C01EB16 | M01AE01 | G02CC01 | R02AX02";"M02AA - Antiinflammatory preparations, non-steroids for topical use | M01AE - Propionic acid derivatives | C01EB - Other cardiac preparations | M01AE - Propionic acid derivatives | G02CC - Antiinflammatory products for vaginal administration | R02AX - Other throat preparations";"M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN | M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | C01E - OTHER CARDIAC PREPARATIONS | M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | G02C - OTHER GYNECOLOGICALS | R02A - THROAT PREPARATIONS";"M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN | M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | C01 - CARDIAC THERAPY | M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | G02 - OTHER GYNECOLOGICALS | R02 - THROAT PREPARATIONS";"M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM | C - CARDIOVASCULAR SYSTEM | M - MUSCULO-SKELETAL SYSTEM | G - GENITO URINARY SYSTEM AND SEX HORMONES | R - RESPIRATORY SYSTEM";"CHEMBL521"
